The QualityStocks Daily Friday, July 19th, 2024

Today's Top 3 Investment Newsletters

Ross Givens(SERV) $7.5500 +187.07%

Tiny Gems(AUGX) $2.2600 +146.62%

QualityStocks(GLXZ) $2.8400 +101.42%

The QualityStocks Daily Stock List

Galaxy Gaming, Inc. (GLXZ)

RedChip, QualityStocks, The Green Baron, TaglichBrothers, SmallCapVoice, MarketBeat, FeedBlitz, Marketbeat.com, TradersPro, Stock Profile, Red Chip and Penny Stocks Profile reported earlier on Galaxy Gaming, Inc. (GLXZ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Galaxy Gaming, Inc. is a developer and distributor of casino table games and enhanced systems. The Company develops, manufactures, and distributes unique proprietary table games, state-of-the-art electronic wagering platforms and enhanced bonusing systems. These are for land-based, riverboat, cruise ships and online casinos around the world. Galaxy Gaming has its corporate office in Las Vegas, Nevada.

The proprietary products are marketed to the above-mentioned entities to enhance their gaming floor operations and improve profitability, productivity and security. This is while offering popular innovative gaming entertainment content and technology to their players. Game concepts and intellectual property (IP) associated with the games are normally protected by patents, trademarks and copyrights.

Galaxy Gaming sell its products mainly through its internal sales force. The products are sold to casinos throughout North America, the Caribbean, the British Isles, Europe, Africa and to cruise ships and internet gaming sites globally.

Galaxy Gaming, Inc. (GLXZ), closed Friday's trading session at $2.84, up 101.4184%, on 871,686 volume. The average volume for the last 3 months is 6.015M and the stock's 52-week low/high is $0.55/$3.60.

Virpax Pharmaceuticals (VRPX)

QualityStocks, MarketClub Analysis, The Online Investor, Schaeffer's and 360 Wall Street reported earlier on Virpax Pharmaceuticals (VRPX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Virpax Pharmaceuticals Inc. (NASDAQ: VRPX) is a preclinical stage biopharmaceutical firm that is engaged in the development and manufacture of non-addictive and non-opioid pharmaceutical products.

The firm has its headquarters in Berwyn, Pennsylvania and was incorporated in 2017 on May 12th by Anthony P. Mack. It operates as part of the pharmaceutical and medicine manufacturing industry, under the healthcare sector, in the biotech and pharma sub-industry. The firm serves consumers in the U.S.

The company manufactures its pharmaceuticals products through the use of drug delivery systems for pain management. It has global rights to an intranasal NCE (New Chemical Entity) that delivers encephalin to the brain for the treatment of PTSD and the management of cancer pain as well as chronic pain, using its Molecular Envelope Technology.

The enterprise’s product pipeline is made up of an encephalin intranasal spray for chronic and acute pin dubbed Envelta (NES100); a formulation indicated for chronic osteoarthritis affecting the knee, known as OSF200; a bupivacaine liposomal gel indicated for the management of post-op pain dubbed LBL100 (Probudur) and a metered-dose diclofenac spray film developed to manage acute musculoskeletal pain, known as Epoladerm. In addition to this, the enterprise is involved in the development of a masking spray that decreases or prevents the intensity or the risk of viral infections like the coronavirus in people, known as MMS019; and a formulation to manage PTSD, dubbed PES200.

The company recently announced that it would be submitting an Investigational New Drug application for its Envelta formulation for chronic pain. The approval of the application by the FDA will allow human trials to begin, bringing the firm one step closer to commercialization, if the treatment proves itself to be efficacious. The treatment’s success will not only be beneficial to patients but also bring in more investors into the firm, which will be good for the company’s growth.

Virpax Pharmaceuticals (VRPX), closed Friday's trading session at $1.7, up 32.8125%, on 48,346,607 volume. The average volume for the last 3 months is 80,095 and the stock's 52-week low/high is $0.4603/$10.00.

Can Fite Biopharma (CANF)

RedChip, StockMarketWatch, Streetwise Reports, BUYINS.NET, INO.com Market Report, QualityStocks, MarketBeat, MarketClub Analysis, OTCBB Journal, Stock Analyzer, First Penny Picks, StocksImpossible, StreetInsider, StockEarnings, Broad Street, PennyStockProphet, TradersPro, Jason Bond, StockOodles, InvestorPlace, CRWEFinance, Marketbeat.com, InvestorsUnderground, Buzz Stocks, HotOTC, CRWEPicks, CRWEWallStreet, DrStockPick, Investing Futures, Red Chip, Weekly Newsletter, WealthMakers, Top Stock Picks, The Street, The Stock Dork, Street Insider, PennyOmega, StockHotTips, OTC Journal, Profitable Trader Authority, PennyToBuck, Zacks, PennyStockScholar, BestOtc, Penny Pick Finders, OTCtipReporter and StockOnion reported earlier on Can Fite Biopharma (CANF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Can Fite Biopharma Ltd. (NYSE American: CANF) (FRA: CF5B) (TLV: CANF) is a clinical-stage biopharmaceutical firm that is engaged in developing small molecule therapeutic products used to treat erectile dysfunction and inflammatory ailments as well as liver disease and cancer.

The firm has its headquarters in Petach-Tikva, Israel and was incorporated in 1994, on September 11th by Ilan Cohn and Pnina Fishman. Prior to its name change in January 2001, the firm was known as Can-Fite Technologies Ltd.

The company is party to a collaboration agreement with Univo Pharmaceuticals which entails the identification and co-development of formulations of marijuana components for the treatment of metabolic, autoimmune and inflammatory diseases, as well as cancer. It also has a collaboration agreement with CMS Medical which entails the development, manufacture and commercialization of its Namodenoson and Piclidenoson formulations.

The enterprise’s candidates include CF602, which is in preclinical trial for erectile dysfunction treatment; and, Namodenoson (CF102), which is in a phase 2 trial for treating non-alcoholic steatohepatitis and has concluded phase 2 clinical trials evaluating its effectiveness in treating hepatocellular carcinoma. It also develops Piclidenoson (CF101), which is undergoing phase 2 trials for the treatment of the coronavirus and phase 3 clinical trials for psoriasis treatment. The enterprise is also engaged in the development of predictive biomarker blood test kits for A3AR.

The firm is set to begin its phase 3 Namodenoson trial after obtaining agreement on the protocol and plans to submit from the European Medicines Agency and the U.S. FDA. This brings the formulation one step closer to approval, which will benefit patients with the indications the candidate has been developed for as well as boost investments into the firm.

Can Fite Biopharma (CANF), closed Friday's trading session at $4.5, up 15.3846%, on 177,771 volume. The average volume for the last 3 months is 18,448 and the stock's 52-week low/high is $1.81/$4.5599.

Serina Therapeutics (SER)

Streetwise Reports reported earlier on Serina Therapeutics (SER), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Serina Therapeutics Inc. (NYSE American: SER) (FRA: 2BO) is a biotechnology firm focused on the development of drugs for the treatment of neurological illnesses and pain.

The firm has its headquarters in Huntsville, Alabama and was incorporated in 2024, on March 26th by Michael D. Bentey and J. Milton Harris. Prior to its name change, the firm was known as AgeX Therapeutics Inc. It operates as part of the biotechnology industry, under the healthcare sector. The firm primarily serves consumers in the United States.

The company develops polymer technology, which has been designed to optimize drug delivery to maximize compliance, therapeutic outcomes, safety, and quality of life for patients. Its POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. Its POZ Platform partners are at the forefront in advancing LNP delivery technology to develop RNA therapeutics.

The enterprise’s lead product candidate is SER 252, a POZ conjugate for the treatment of Parkinson's disease. It also develops SER 214 for the treatment of Parkinson's disease; SER 228 to treat epilepsy; and SER 227 for long-acting pain relief. In addition to this, the enterprise develops POZ technology in lipid nanoparticle delivered ribonucleic acid vaccines for infectious illnesses.

The firm recently appointed a new senior VP of Chemistry, Manufacturing, and Controls, who has over two decades of experience in drug development. This move shall be instrumental as the firm continues to advance its pipeline and bring innovative therapies to patients.

Serina Therapeutics (SER), closed Friday's trading session at $9.71, up 9.8416%, on 22,402 volume. The average volume for the last 3 months is 5.336M and the stock's 52-week low/high is $5.9262/$31.164137.

CrowdStrike Holdings (CRWD)

Schaeffer's, InvestorPlace, MarketBeat, MarketClub Analysis, The Street, StockEarnings, StocksEarning, Zacks, Kiplinger Today, Early Bird, Trades Of The Day, Daily Trade Alert, TradersPro, Cabot Wealth, StreetInsider, TipRanks, Money Wealth Matters, The Online Investor, The Wealth Report, Wealth Insider Alert, Top Pros' Top Picks, INO Market Report, CNBC Breaking News, The Night Owl, Louis Navellier, FreeRealTime, Jeff Bishop, Eagle Financial Publications, InsiderTrades, AllPennyStocks, Timothy Sykes, StockMarketWatch, DividendStocks, Smart Investing Society, Earnings360, Wealth Daily, Investing Daily, Investopedia, wyatt research newsletter, InvestorsUnderground, Jon Markman’s Pivotal Point, Rick Saddler and Hit and Run Candle Sticks reported earlier on CrowdStrike Holdings (CRWD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The recent global outage, triggered by a software update from cybersecurity firm CrowdStrike Holdings (NASDAQ: CRWD), has had a profound impact on systems worldwide, including airports and stock exchanges. This incident, caused by a defect in a content update for Windows hosts, underscores the critical role cybersecurity firms play in maintaining the digital infrastructure’s integrity. CrowdStrike, a leading player in the cybersecurity space, offers solutions like the Falcon Sensor, part of its Endpoint Detection and Response platform, designed to protect systems from cyber threats. However, this incident has brought to light the challenges even leading cybersecurity firms face in ensuring the reliability of their updates.

CrowdStrike’s CEO, George Kurtz, has acknowledged the issue, emphasizing that it was not related to a security incident or cyberattack but rather a defect in a software update. The company’s swift response to deploy a fix highlights the complexities involved in managing cybersecurity solutions that are integral to the functioning of critical global infrastructure. Despite the efforts, the continued crashes related to the Falcon Sensor have had widespread repercussions, affecting not just the cybersecurity landscape but also the operations of businesses and public services globally.

On the other hand, Microsoft Corp. (NASDAQ: MSFT), whose Windows operating system was directly impacted by the faulty update, has also felt the ripple effects of the outage. With its share price experiencing a decrease of $4.235 to $436.135, the incident has not only highlighted the vulnerabilities in the world’s digital infrastructure but also the financial implications for major tech companies. Microsoft’s acknowledgment of the impact on Windows devices and its guidance provided on the Azure status page reflect the broader economic consequences of such disruptions.

The incident’s global reach and its effect on core internet infrastructure have brought to the forefront the interconnectedness of modern digital services and the potential for significant economic fallout from such disruptions. With a market capitalization of about $3.24 trillion, Microsoft’s financial performance and stock market valuation are indicative of the broader tech industry’s susceptibility to cybersecurity incidents. The fluctuation in MSFT’s shares, ranging from a low of $309.45 to a high of $468.35 over the past year, further illustrates the volatile nature of tech stocks in response to unforeseen challenges.

This event serves as a stark reminder of the critical importance of cybersecurity and the potential consequences when systems that the world relies on are disrupted. As companies like CrowdStrike and Microsoft navigate the aftermath of this outage, the incident underscores the ongoing challenges in safeguarding digital infrastructure against the complexities of software updates and cybersecurity threats.

To view Microsoft’s most recent news release, visit https://ibn.fm/FXGQN

About Microsoft

Microsoft creates platforms and tools powered by AI to deliver innovative solutions that meet the evolving needs of our customers. The technology company is committed to making AI available broadly and doing so responsibly, with a mission to empower every person and every organization on the planet to achieve more. For more information, visit the company’s website at www.Microsoft.com.

CrowdStrike Holdings (CRWD), closed Friday's trading session at $304.96, off by 11.1033%, on 42,145,705 volume. The average volume for the last 3 months is 588,337 and the stock's 52-week low/high is $140.52/$398.3271.

Green Thumb Industries Inc. (GTBIF)

InvestorPlace, QualityStocks, MarketBeat, Wealth Insider Alert, Cabot Wealth, CannabisNewsWire, Trades Of The Day, TradersPro, Daily Trade Alert, The Street, The Online Investor, CFN Media Group, StreetInsider, Zacks, Trading For Keeps, wyatt research newsletter, Prism MarketView, Kiplinger Today, Top Pros' Top Picks, Daily Profit and Technology Profits Daily reported earlier on Green Thumb Industries Inc. (GTBIF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

A recent scientific assessment of scholarly studies on human sexuality and cannabis has found that there is a complex link between sex and cannabis use. However, the general consensus is that cannabis tends to increase the frequency, enjoyment and desire for sex.

The review, published in the “Psychopharmacology Journal,” suggests that higher amounts of cannabis may impair performance and desire, while smaller doses may be more favorable to sexual fulfillment. The effects also appear to vary based on gender.

The study’s authors noted that marijuana can improve intimacy with partners, reduce shame and anxiety, lessen inhibitions and increase sexual pleasure. The authors also observed enhanced sensory sensations during sex and greater enjoyment during masturbation, suggesting that cannabis has a major effect on sex experiences.

The review emphasizes that sex is influenced by a variety of emotional and physical factors, and cannabis affects people in a holistic way that can influence both the emotional and physical aspects of sexual experiences.

Though there is limited study on women’s experiences, women appear to gain more from cannabis use in terms of its sexual effects than men do. The authors noted that low dosages of hypnotic cannabinoids and sedatives, such as THCV and THC, may lessen sexual activity anxiety, which may increase arousal and desire for sexual activity, particularly in women.

For men, findings are mixed, with some studies indicating that marijuana use can lead to premature and delayed ejaculation as well as erectile dysfunction, while others suggest the opposite.

Dosage and frequency of marijuana use are key factors, although more research is needed. Higher sexual function seems to be associated, at least generally, with regular cannabis use. A survey cited in the review found that women who used cannabis more frequently performed better than those who did so infrequently on tests of female sexual function.

Increased cannabis use frequency correlated with better overall FSFI scores and improvements in orgasm, desire, satisfaction domains, arousal and orgasm. Higher frequency categories also saw a decline in reports of sexual dysfunction. According to one study, women who used cannabis regularly were twice as likely as infrequent users to report having satisfying orgasms.

Men who regularly use cannabis have been linked to orgasm-related issues, such as early or delayed ejaculation. However, another study found no link between the frequency of cannabis usage and problems maintaining an erection.

Given the varied and occasionally contradictory results, the researchers have advocated for additional studies to account for other variables. The authors noted that cannabis has a varied impact on human sexuality, including both negative and positive. They emphasized the need for additional study to understand how marijuana affects sexuality, as doing so may lessen harm and even enhance human experiences.

With the insights so far gleaned, consumers can be assured that moderately using various marijuana products from the hundreds of licensed companies such as Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) could be beneficial to their well-being without triggering notable adverse events.

Green Thumb Industries Inc. (GTBIF), closed Friday's trading session at $11.15, off by 4.9446%, on 192,296 volume. The average volume for the last 3 months is 46.21M and the stock's 52-week low/high is $6.42/$16.33.

Rivian Automotive Inc. (RIVN)

Schaeffer's, InvestorPlace, QualityStocks, The Street, Kiplinger Today, MarketClub Analysis, MarketBeat, Early Bird, StockEarnings, INO Market Report, Investopedia, The Online Investor, Zacks, GreenCarStocks, Daily Trade Alert, Louis Navellier, AllPennyStocks, TipRanks, Trades Of The Day, StocksEarning, The Night Owl, BillionDollarClub, InvestorIntel, DividendStocks, InvestorsUnderground, Cabot Wealth, FreeRealTime, 360 Wall Street, Premium Stock Alerts, Hit and Run Candle Sticks, Top Pros’ Top Picks, Rick Saddler, bullseyeoptiontrading, Investors Underground and Top Pros' Top Picks reported earlier on Rivian Automotive Inc. (RIVN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Rivian Automotive Inc. (NASDAQ: RIVN) entered into a deal with Volkswagen (VW), a move that has sparked a lot of chatter in the electric vehicle market. The $5 billion deal, after an initial $1 billion investment, aims to codevelop software platforms for both companies’ electric vehicles, providing Rivian with much-needed financial support and leveraging VW’s extensive manufacturing capabilities and global reach.

On the other hand, VW, one of the largest automotive giants, will receive access to cutting-edge software expertise. In an interview with CNBC, Cyrus Mewawalla, head of thematic intelligence at GlobalData, shared that Volkswagen has fallen behind in two critical areas: on electric vehicles and autonomous driving and other software within the car. Rivian is strong on both.

For many, this partnership sounds like a match made in heaven. However, EV market analysts believe this deal could be masking some underlying issues.

One of these underlying issues in the EV market that analysts are concerned about is the ongoing demand problem for EVs. Rivian has been experiencing numerous delays, despite the company having one of the best designs in the market.

In the second quarter, Rivian produced 13,790 EVs, a mere 1.5%  increase from what it achieved in the first quarter. The company still believes it will be able to make about 57,000 units by the end of the year. Analysts believe production has worsened because of the rise in electricity prices and the high upfront cost of EV purchasing.  This is also the reason why giant EV makers, such as Tesla, Lucid, BYD and others, have resorted to slashing prices for their models.

This VW deal could help Rivian achieve its goal but won’t guarantee dominance in the EV market. What’s more, the deal with VW will help overcome the significant financial struggles Rivian has been experiencing lately due to limited deliveries and operational losses. As of March 2024, the company had $7.85 billion in cash, which is far less than what it had at the same time last year, which was $11.78 billion. Reports also show that the company’s stock has dropped by 50% this year, signifying that all is not well. Therefore, a partnership with VW is a much-needed lifeline that could see things turn around for the company and its investors.

Additionally, the deal between the two companies has caused analysts to question the future of VW’s electric vehicle strategy. The German automobile manufacturer had plans to transition to electric vehicles but had been met with software glitches that put the company behind the curve. This partnership with Rivian means that the company needs assistance from experts to help catch up with giants such as Tesla.

Rivian Automotive Inc. (RIVN), closed Friday's trading session at $16.75, off by 0.887574%, on 25,909,034 volume. The average volume for the last 3 months is 48.023M and the stock's 52-week low/high is $8.26/$28.06.

Marathon Digital Holdings Inc. (MARA)

MarketClub Analysis, Schaeffer's, InvestorPlace, QualityStocks, INO Market Report, StockMarketWatch, MarketBeat, StockEarnings, StocksEarning, TradersPro, Early Bird, Zacks, Investors Underground, InvestorsUnderground, Lebed.biz, BUYINS.NET, The Online Investor, Trades Of The Day, The Street, TraderPower, Daily Trade Alert, Marketbeat.com, 360 Wall Street, FreeRealTime, CryptoCurrencyWire, PoliticsAndMyPortfolio, BillionDollarClub, Wall Street Mover, TopPennyStockMovers, Investment House, Wealth Insider Alert, FeedBlitz, The Wealth Report, StreetAuthority Daily, Kiplinger Today, Stock Analyzer, AllPennyStocks, Barchart, RedChip, Wealth Daily, Rick Saddler, TradingPub, DividendStocks, DreamTeamNetwork, Inside Trading, Trading Pub, Stock Beast, Promotion Stock Secrets, StockOodles, ProsperityPub, Investment News Daily, StreetInsider, Lance Ippolito, Street Insider, Jeff Bishop and Eagle Financial Publications reported earlier on Marathon Digital Holdings Inc. (MARA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Recent comments from Fed Chair Jerome Powell caused the dollar to slightly decline, while cryptos experienced an uptick due to speculation that former President Donald Trump’s assassination attempt increased his chances of reelection. Trump, known for his procrypto stance, has yet to outline specific policies for the cryptocurrency sector.

Following the incident, betting odds for Trump’s victory improved. PredictIt, an online betting platform, showed Trump’s election odds climbing to 67 cents from 60 cents on last week, while Biden’s odds were at 27 cents. The dollar often strengthens with “Trump trade,” which includes assets expected to do well under Trump’s administration, characterized by aggressive trade policies and relaxed regulations for specific industries.

However, this initial boost was short lived, and the dollar retreated from its earlier levels.

The greenback also dropped sharply when Powell started his speech. He pointed out that there was some indication from three inflation reports from the second quarter that the rate of price increases was stabilizing toward the fed’s objective, indicating the possibility of a rate cut in the near future.

According to Bannockburn Global Forex’s head market analyst, Marc Chandler, Powell’s speech did not quite reaffirm the market’s already-held optimism about a September rate decrease.

After peaking at 104.31, the dollar index, which compares the value of the U.S. dollar to a basket of other currencies, fell 0.07% to 104.22, while the euro fell 0.09% to $1.0897. The British pound dropped to $1.2964, down 0.22%.

According to the CME’s FedWatch Tool, markets are fully expecting the fed to drop interest rates by at least 25 basis points in September after recent data showed that consumer prices fell in June for the first time in four years.

Cryptocurrency prices surged, with Bitcoin rising more than 6% to $63,808 after hitting a three-week high of $63,838.86. Ether also increased by more than 7%, to $3,417. The dollar remained steady against the Japanese yen at 157.89, having fallen to 157.15 during Powell’s speech, its lowest level since June, before quickly recovering.

The Bank of Japan (BoJ) is believed to have interfered in the market last week to prop up the value of the Japanese yen in response to the U.S. inflation data, which was lower than anticipated. Authorities may have spent as much as $22.4 billion (3.57 trillion yen) on Thursday for this reason, according to the central bank’s data.

According to FX trader, Helen Given, the yen is likely to appreciate against any indication that the fed may lower interest rates more or sooner than expected.

Crypto companies such as Marathon Digital Holdings Inc. (NASDAQ: MARA) and other industry players are likely to watch how any fed action on interest rates impacts the crypto market over the coming months.

Marathon Digital Holdings Inc. (MARA), closed Friday's trading session at $24.73, up 4.5666%, on 61,002,934 volume. The average volume for the last 3 months is 355,183 and the stock's 52-week low/high is $7.16/$34.09.

Royal Gold Inc. (RGLD)

TopStockAnalysts, Streetwise Reports, StreetAuthority Daily, QualityStocks, InvestorPlace, TradingAuthority Daily, Top Pros' Top Picks, MarketBeat, The Street, Daily Wealth, StreetInsider, Daily Trade Alert, SmarTrend Newsletters, Zacks, All about trends, TheStockAdvisor, Energy and Capital, MarketClub Analysis, Money Morning, DividendStocks, The Growth Stock Wire, TheStockAdvisors, Trades Of The Day, Dividend Opportunities, Schaeffer's, Wyatt Investment Research, MiningNewsWire, Marketbeat.com, Barchart, Uncommon Wisdom, Stansberry Research, Lebed.biz, Investor Update, Wealth Daily, Daily Profit, Investment U, National Inflation Association, Stockhouse, The Online Investor, Traders For Cash Flow, Money and Markets, TradingMarkets, Trade of the Week, Market Intelligence Center Alert, Forbes, Greenbackers, Outsider Club, Weekly Wizards, Kiplinger Today, FNNO Newsletters, Eagle Financial Publications, Dynamic Wealth Report, TradersPro, Bourbon and Bayonets, BestChartNow, Wealth Insider Alert, ChartAdvisor, AllPennyStocks, Investopedia, Penny Stock Chaser, PowerRatings Stocks, Profits Run, Short Term Wealth, Market FN, Market Authority, GorillaTrades, StocksEarning, FreeRealTime, The Best Newsletters, Investing Futures, Inside Investing Daily, INO.com Market Report, One Hot Stock, Hit and Run Candle Sticks and Stocks That Move reported earlier on Royal Gold Inc. (RGLD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The World Gold Council (WGC) defines gold exchange traded funds (ETFs) as regulated securities that hold gold in physical form. This includes mutual funds, closed-end funds and open-ended funds that trade on regulated exchanges.

The organization tracks gold ETFs either by the equivalent value of their holdings in U.S. dollars, or the physical quantity of gold they hold. In addition, the WGC monitors how these assets change through time by examining fund flows and demand.

Latest data from the WGC shows that physically backed gold ETFs globally have lost $6.7 billion between Jan. 1 and June 30 of this year. This performance by the exchange traded funds makes it their worst first half in a year since 2013. A report by the organization showed that total holdings had also reduced to 3,105 tons during this time. Holdings previously stood at 3,225 tons, representing a 3.9% drop.

In a statement, the World Gold Council explained that collective outflows in Europe and North America were significantly higher, especially when compared to inflows into Asian funds during the period, which stood at about $3 billion. The report highlighted that gold ETF investors in the West also didn’t react to the increase in the price of gold as expected.

An increase in the price of this precious metal is known to drive investment flows higher. This effect is even more pronounced in times of high interest rates.

The report also called attention to the fact that the impressive performance of gold in nondollar currencies and weaknesses in said currencies attracted investors to Asia. With regard to regions, WGC observed that Asia was the sole region that saw positive flows, recording $3.1 billion in inflows for the first half of this year.

In a statement, the WGC explained that this was the strongest first half of the year performance for Asian funds ever, primarily driven by peak inflows into Japan and China. For Asian funds, total assets under management for this half of the year hit $14 billion. Collective holdings also increased by 41 tons.

On the other hand, European funds saw outflows totaling $8 billion. However, total assets under management in European funds recorded a 6.3% increase, attributable to the increase in gold’s price.

In North America, the region recorded outflows totaling $4.9 billion, its highest figure in three years. Despite this pit, a 13% increase in the price of gold resulted in a more than 7% increase in total assets under management for the North American region.

It would be interesting to see an analysis of how these outflows from gold ETFs compare with the performance of various gold stocks such as Royal Gold Inc. (NASDAQ: RGLD) over the same period under consideration.

Royal Gold Inc. (RGLD), closed Friday's trading session at $138.18, off by 0.3533569%, on 251,551 volume. The average volume for the last 3 months is 1.163M and the stock's 52-week low/high is $100.55/$140.95.

Workhorse Group Inc. (WKHS)

Green Car Stocks, InvestorPlace, QualityStocks, MarketClub Analysis, Schaeffer's, Kiplinger Today, StocksEarning, MarketBeat, StockMarketWatch, StockEarnings, TradersPro, StreetInsider, Early Bird, The Street, Trades Of The Day, GreenCarStocks, The Online Investor, Daily Trade Alert, TopPennyStockMovers, TraderPower, BUYINS.NET, Wealth Insider Alert, Money Wealth Matters, Zacks, StockOodles, Marketbeat.com, Cabot Wealth, Jason Bond, InvestorsUnderground, PoliticsAndMyPortfolio, The Night Owl, Daily Market Beat, The Wealth Report, Energy and Capital, Wealth Daily, Profitable Trader Authority, Stock Beast and The Best Newsletters reported earlier on Workhorse Group Inc. (WKHS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

EV industry players say electric vehicles have the potential to benefit energy grids across the world. With a growing number of countries working to electrify their transportation segments, many electrification skeptics fear a widespread transition to new energy vehicles, such as plug-in hybrids and battery electric vehicles (BEVs), could place significant stress on energy grids.

These vehicles would be entirely powered by electricity, but skeptics say the energy grids in most countries cannot support a mass transition to electric vehicles. However, top EV industry players believe electric cars could bolster energy grids in nations that pursue electrification. Referring to EVs as “batteries on wheels,” they say they could feed energy into national grids if wind and solar farms cannot produce enough power to cover energy demand.

This would be thanks to vehicle-to grid technology, a somewhat recent feature that allows electric cars to both take in and discharge energy. Consequently, electric cars equipped with this feature can also function as massive batteries capable of even powering households for a day or two. According to industry players, bidirectional charging could make electric cars an asset rather than a liability for national grids, contradicting skeptics who believe plugging millions of EVs into grids could have negative consequences.

Some of their projections see electric cars drawing too much electricity from grids and plunging people into darkness. In Britain, publications that are skeptical of net-zero emission goals are now warning that EVs could cause catastrophic blackouts by overwhelming the country’s national grid when solar- and wind-energy generation are at their lowest. One article claimed that electric vehicles rather than enemy forces would plunge the United Kingdom into darkness.

However, many of the folks involved in the EV industry argue that transitioning to electric cars provides the opportunity to develop a smarter and, hopefully, greener energy system with more opportunities to generate revenue. Wind farms and solar panels have largely replaced the UK’s coal-fired power stations, and smart technology can be used to overcome their intermittent energy generation by ensuring excess energy from peak generation times is stored and later fed back into the grid when demand peaks.

This could be achieved by leveraging stationary power-storage facilities as well as electric cars with bidirectional charging. According to home charger company Myenergy, the grid could receive over 1GW worth of demand shift flexibility, representing more than 98% of the capacity provided by the largest fossil fuel-fired energy providers, if each of its compatible installed chargers has balancing services enabled.

There is likely to be a surge in the inclusion of bidirectional charging systems in the EVs made by various manufacturers such as Workhorse Group Inc. (NASDAQ: WKHS) in order to help motorists have a backup power source in the event of a blackout in their areas of residence.

Workhorse Group Inc. (WKHS), closed Friday's trading session at $1.67, off by 11.6402%, on 1,208,796 volume. The average volume for the last 3 months is 21.627M and the stock's 52-week low/high is $1.285/$27.20.

Tilray Brands Inc. (TLRY)

Schaeffer's, InvestorPlace, QualityStocks, StockEarnings, StocksEarning, The Street, MarketClub Analysis, MarketBeat, Trades Of The Day, Daily Trade Alert, StockMarketWatch, Kiplinger Today, StreetInsider, The Online Investor, Wealth Insider Alert, Market Intelligence Center Alert, BUYINS.NET, Zacks, Investopedia, CFN Media Group, CannabisNewsWire, CNBC Breaking News, INO Market Report, The Street Report, Early Bird, Daily Profit, StreetAuthority Daily, FreeRealTime, Tip.us, The Rich Investor, InvestmentHouse, Top Pros' Top Picks, Inside Trading, Prism MarketView, Trading Concepts, Trading For Keeps, Investment House, Investors Alley, Eagle Financial Publications, InsiderTrades, Outsider Club, wyatt research newsletter, Wealth Daily, VectorVest, TradersPledge, TheTradingReport, The Night Owl, StrategicTechInvestor, Money Morning, Rick Saddler, InvestorsObserver Team, AllPennyStocks, MarketClub, Marketbeat.com, Louis Navellier, Jim Cramer, Jason Bond, InvestorsUnderground and Stock Up Featured reported earlier on Tilray Brands Inc. (TLRY), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Last month, legislators in Delaware approved a measure that would allow medical cannabis licensees in the state to apply for conversion licenses to cultivate and sell recreational marijuana. Governor John Carney is expected to sign the measure in the coming weeks.

The recently approved measure was sponsored by Representative Ed Osienski, who revealed that cultivation was the most difficult pathway to use to enter the marijuana industry. This, Osienski explained, was because of the larger investments needed to cover the needed infrastructure, such as ventilation and lighting as well as the need for more time for cultivation.

This was why the state had decided to go down the path that would fill the current gap, as it was less demanding. Legislators had decided that this would be done by allowing those who already had facilities and licenses to be able to cultivate marijuana and manufacture products like gummies.

Issuance of these conversion licenses is set to begin in November, with Rob Coupe noting that if the measure hadn’t been approved, retail sales would’ve had to launch in late 2026. It had been expected that applicants who obtain the new growing licenses would take about 12 months longer to launch their operations, and also to cultivate crops for retail sale.

The new course taken by the state establishes faster pathways though, allowing the adult-use market to become operational faster and making cannabis legally available to the general public. The state expects that conversion licenses will generate a little more than $4 million in application fees, which shall be directed to a fund for social-equity applicants. These applicants are set to be awarded 47 of the conversion licenses, which total 125.

Currently, growing licenses go for $200,000 apiece. Parties that want to obtain a license to manufacture, test or retail cannabis have to part with an additional $100,000.

Legislators also allocated another $2 million into this fund, which is to be awarded to aspiring social-equity marijuana entrepreneurs. For these entrepreneurs to be eligible, they are required to own no less than 51% of the business and meet one of the following criteria:

  • has/had a spouse, parent, child, dependent or legal guardian who was convicted of a cannabis crime.
  • been convicted of a cannabis-related offense. This excludes those who sold the drug to a minor or sold more than 11 pounds of marijuana.
  • lived for no less than five of the last ten years in an area that was disproportionately affected by the war on drugs.

Basically, these are targeted areas that have seen high numbers of arrests related to cannabis in the last decade. Applicants can cross check to see if their addresses are in these targeted areas on the state’s website. The state’s social-equity program is focused on creating opportunities for individuals and/or communities that were oppressed by marijuana prohibition.

The entire cannabis industry, including brands such as Tilray Brands Inc. (NASDAQ: TLRY) (TSX: TLRY), will be hoping that the adult-use market in Delaware gets off to a good start and avoids the hiccups that have plagued some markets, including New York state.

Tilray Brands Inc. (TLRY), closed Friday's trading session at $1.79, off by 2.1858%, on 14,068,042 volume. The average volume for the last 3 months is 5.278M and the stock's 52-week low/high is $1.60/$3.40.

C3.ai Inc. (AI)

Schaeffer's, InvestorPlace, The Online Investor, Marketbeat, INO Market Report, MarketClub Analysis, Early Bird, Marketbeat.com, StreetInsider, The Street, Zacks, QualityStocks, Investopedia, The Wealth Report, InvestorsUnderground, Daily Trade Alert, FreeRealTime, Street Insider, The Street Report, Investment House, StrategicTechInvestor, StreetAuthority Daily, DividendStocks, Total Wealth, Cabot Wealth, Trades Of The Day, AllPennyStocks, 360 Wall Street, Eagle Financial Publications, Hit and Run Candle Sticks, Dividend Opportunities, CNBC Breaking News, InsiderTrades, Investiv, Prism MarketView, Wall Street Greek, Wall St. Warrior, TradersPro, TipRanks, Timothy Sykes, Tim Bohen, The Night Owl, MicrocapAlliance, Stansberry Research, Investors Alley, OilAndEnergyInvestor, Money Wealth Matters, Money and Markets, 247 Market News, Louis Navellier, Liberty Through Wealth, Kiplinger Today and StockMarketWatch reported earlier on C3.ai Inc. (AI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Researchers at MIT have developed a new tool that enables database users to easily carry out statistical analyses of tabular data. The tool, GenSQL, is a generative artificial intelligence system for databases. It has been designed to assist users in detecting anomalies, making forecasts, fixing errors, generating synthetic data or guessing mission values.

For example, if the system analyzed medical data from an individual who has been diagnosed with hypertension, it may catch a reading that is low for the individual but would otherwise be considered normal.

The tool has been designed to automatically integrate a generative probabilistic artificial intelligence model with a tabular dataset. This allows the system to alter its decision-making based on new data while also factoring in uncertainty.

Furthermore, GenSQL can be used to analyze synthetic data that imitates actual data in a database. This may be particularly useful in situations where sensitive data can’t be shared without authorization, such as patient health records.

The recently rolled-out tool is based on SQL, a programming language for database manipulation and creation that is used by millions of developers globally. SQL, which stands for structured query language, was launched in the 1970s. This language is mainly used to store and manipulate data in a database and has undergone various revisions to keep up with the evolving needs of the database field.

Individuals can ask questions on any information on SQL using key words and filtering, grouping or summing database records.

Vikash Mansinghka, senior author of the paper on GenSQL, stated that SQL mainly centered on asking questions of a database in an advanced language. Mansinghka explained that there was a need for an analogous language that taught individuals reasonable questions they could ask a computer.

A comparison between other popular AI-based approaches and GenSQL led researchers to the discovery that GenSQL produced more accurate results and was faster. Additionally, GenSQL used probabilistic models that were explainable, making it easy for users to read and edit them.

Mathieu Huot, lead author of the study, explained that GenSQL allowed users to query their data and models without knowing all the details.

Other researchers that took part in the study included MIT graduate students Alexander Lew and Matin Ghavami; Zane Shelby and Ulrich Schaechtle, of Digital Garage; Cameron Freer, a research scientist; assistant professor Feras Saad of Carnegie Mellon University; and MIT professor Martin Rinard, from the department of electrical engineering and computer science.

The study was presented recently at the ACM Conference on Programming Language Design and Implementation.

Other enterprises such as C3.ai Inc. (NYSE: AI) are also introducing new artificial intelligence solutions on the market. This suggests that these technologies could soon make their presence felt in every industry within a few years.

C3.ai Inc. (AI), closed Friday's trading session at $27.83, off by 1.4518%, on 2,778,092 volume. The average volume for the last 3 months is 32,430 and the stock's 52-week low/high is $20.23/$44.90.

The QualityStocks Company Corner

Nutriband Inc. (NASDAQ: NTRB)

The QualityStocks Daily Newsletter would like to spotlightFathom Nutriband Inc. (NASDAQ: NTRB) .

Nutriband (NASDAQ: NTRB), a pharmaceutical company with a special focus on transdermal technologies, is inviting investors to a live webinar. Scheduled for July 25, 2024, at 4:15 p.m. ET, this exclusive event will be hosted by RedChip Companies. During the webinar, Nutriband Chairman and President Serguei Melnik and CEO Gareth Sheridan will share insights into the company's current operations and upcoming milestones.

To register for the free webinar, visit https://ibn.fm/ZZkgn

To view the full press release, visit https://ibn.fm/F05yE

Nutriband Inc. (NASDAQ: NTRB) is engaged in the development of a portfolio of transdermal pharmaceutical products. The company’s AVERSA™ technology can be incorporated into any transdermal patch and includes aversive agents to prevent abuse, diversion, misuse and accidental exposure to drugs with abuse potential, specifically opioids.

AVERSA technology has the potential to improve the safety profile of transdermal drugs susceptible to abuse, such as fentanyl, while making sure that these drugs remain accessible to patients who need them. The technology is covered by a broad intellectual property portfolio with patents granted in the United States, Europe, Japan, Korea, Russia, Canada, Mexico and Australia.

The company’s business model is to apply its transdermal technology to existing FDA-approved drugs with a goal of improving safety, efficacy and patient comfort while qualifying for a limited-development regulatory pathway that reduces the number of clinical trials required for approval of new drugs.

Nutriband has three subsidiaries, including 4P Therapeutics, its clinical and regulatory subsidiary; Pocono Pharmaceutical, a contract manufacturer for a wide range of clients; and Active Intelligence, a developer of sports recovery products. This ownership of manufacturing and clinical development capabilities drastically reduces costs for AVERSA and other technologies.

In April 2024, Nutriband announced that the company had been engaged by and received a first order from Fit For Life Group, a major brand license holder. A fully executed supplier agreement is expected to follow. Nutriband’s wholly owned Active Intelligence subsidiary will act as manufacturer.

The company is headquartered in Orlando, Florida.

Products

Nutriband’s lead product candidate is AVERSA Fentanyl, an abuse-deterrent fentanyl transdermal patch. The company announced in March 2024 that it will submit a New Drug Application to the U.S. Food and Drug Administration seeking approval to market AVERSA Fentanyl.

Nutriband has partnered with Kindeva Drug Delivery, a leading global contract development and manufacturing organization, to incorporate Nutriband’s AVERSA abuse-deterrent transdermal technology into Kindeva’s FDA-approved transdermal fentanyl patch system. Because Nutriband’s abuse-deterrent technology is incorporated into the fentanyl patch but is physically separate from and does not come in contact with the drug layer, the clinical trials typically needed to demonstrate safety and efficacy for a new drug formulation would not be required.

AVERSA Fentanyl has the potential to be the first and only abuse deterrent patch approved anywhere in the world. The company plans to seek an expedited review by the FDA, as has been granted for certain abuse-deterrent oral opioid products, which shortens the regulatory review period to six months from the conventional 10-month FDA review cycle for NDAs.

Nutriband’s AVERSA product development pipeline also includes abuse deterrent versions of currently approved and marketed transdermal patches containing buprenorphine, an opioid used to treat opioid use disorder, and methylphenidate, a central nervous system stimulant used in the treatment of attention deficit hyperactivity disorder (ADHD). Both are labeled with FDA-required warnings for the risk of abuse and misuse, as well as warnings against accidental exposure.

Market Opportunity

Nutriband cites a market analysis report from Boston-based Health Advances, a healthcare and life sciences consulting firm. According to the report, upon FDA approval, AVERSA Fentanyl has the potential to reach peak annual sales of $200 million in the U.S.

The company further states that, should non-abuse-deterrent transdermal fentanyl products lose FDA marketing approval, AVERSA Fentanyl would have greater pricing flexibility and would have the potential to generate more than $500 million in annual revenue.

Management Team

Gareth Sheridan is Co-Founder and CEO of Nutriband. He was Ireland’s ‘Young Entrepreneur of the Year’ in 2014 for establishing Nutriband. He has worked as a Business Mentor with 100 Minds, a social enterprise that brings together some of Ireland’s top college students and connects them with a cause to achieve large charitable goals. He received a B.Sc. in Business and Management from Dublin Institute of Technology.

Serguei Melnik is Co-Founder and President of Nutriband. He has been involved in general business consulting for companies in the U.S. financial markets and setting up legal and financial frameworks for operations of foreign companies in the U.S. He previously was the COO of Florida-based Asconi Corporation. He also was a lawyer in the Department of Foreign Affairs, JSC Bank “Inteprinzbanca,” in Chisinau, Moldova, and prior to that practiced law in Moldova. He is fluent in four languages.

Jeff Patrick, Pharm.D., is Chief Scientific Officer of Nutriband. He currently serves as Director of the Drug Development Institute at the Ohio State University Comprehensive Cancer Center. His prior roles included Global Vice President at Mallinckrodt Pharmaceuticals Inc.; and roles at Dyax, Myogen/Gilead, Actelion and Sanofi-Synthelabo Inc. He was a clinical pharmacist at the University of Tennessee Medical Center and a clinical assistant professor of pharmacy at the University of Tennessee College of Pharmacy.

Gerald Goodman is CFO of Nutriband. He is a certified public accountant with his own firm, Gerald Goodman CPA. He also practiced with Madsen & Associates, CPAs, and was a partner in the accounting firm of Wiener, Goodman & Company. He is also a director of Lifestyle Medical Network Inc., which provides management services to healthcare providers. He is a graduate of Pennsylvania State University, where he received a bachelor’s degree in accounting.

Nutriband Inc. (NASDAQ: NTRB), closed Friday's trading session at $7.24, up 12.7726%, on 36,960 volume. The average volume for the last 3 months is 4.238M and the stock's 52-week low/high is $1.53/$7.40.

Recent News

SuperCom Ltd. (NASDAQ: SPCB)

The QualityStocks Daily Newsletter would like to spotlight SuperCom Ltd. (NASDAQ: SPCB) .

Electronic monitoring ("EM") technology developer SuperCom Ltd. recently reported a new contract with European government clients for its flagship product, its third such contract secured within a three-month period

SuperCom's business with European governments that are seeking its EM technology solutions amounts to over $11 million in new orders since April

SuperCom's flagship EM PureSecurity Suite products provide monitoring solutions that are chiefly being used as an alternative to incarceration

The EM market is growing as criminal justice officials increasingly seek alternatives to incarceration as a means of cutting costs while simultaneously benefitting society through reduced recidivism and increased productive social and labor market participation

SuperCom (NASDAQ: SPCB), a global identity technology provider, reported on July 11 that the company has received new orders from European governments valued at $2.9 million, the third set of orders from European clients in the past 90 days, amounting to a cumulative total of over $11 million in sales during three-month period.

SuperCom Ltd. (NASDAQ: SPCB) provides secured solutions for the e-government, IoT and cybersecurity sectors. Since 1988, the company has been a trusted global provider of traditional and digital identity offerings, providing cutting-edge electronic and digital security solutions to governments and organizations, both private and public, around the world.

SuperCom’s mission is to revolutionize the public safety sector worldwide through proprietary electronic monitoring technology, data intelligence, and complementary services.

The company is headquartered in Tel Aviv, Israel, with offices in California and other regions in the U.S.

Business Units

IoT and Connectivity

SuperCom IoT products and solutions provide advanced electronic monitoring solutions and services to criminal justice agencies, enabling customers to detect unauthorized movement of people, vehicles, and other monitored objects. The company provides an all-in-one, field-proven PureSecurity offender monitoring suite, accompanied by services such as GPS monitoring, home detention, domestic violence prevention, and more. The company’s services are specifically tailored to meet each client’s needs.

SuperCom’s proprietary Puresecurity suite of hardware, connectivity, and software components is the foundation for its criminal justice services and offerings. SuperCom is leveraging its extensive technology expertise to implement groundbreaking artificial intelligence (AI) technologies into various parts of its core offerings. By leveraging the power of AI, SuperCom’s PureSecurity platform can offer new abilities, such as amplified data analysis, predictive modeling, and streamlined automation – all geared toward optimizing decision-making and operational efficiency.

Competitive advantages of SuperCom’s technology include:

  • Long Battery Life (No Tag Charging Required)
  • Ultra Lightweight Form Factor
  • Next-Gen Location Tech
  • Protection of Domestic Violence Victims
  • And More

 

Cybersecurity

In 2015, SuperCom identified the cybersecurity market as a fast-growing space with significant advantages due to synergistic technologies and a shared customer base with its e-Gov and IoT business units. Consequently, SuperCom strategically acquired Prevision Ltd., a company with a strong presence in the market and a broad range of competitive cybersecurity services.

During the first quarter of 2016, SuperCom acquired Safend Ltd., an international provider of cutting-edge endpoint data protection guarding against corporate data loss and theft through content discovery and inspection, encryption methodologies, and comprehensive device and port control.

Both acquisitions significantly expanded the breadth of the company’s global cybersecurity capabilities.

e-Gov

Through proprietary e-government platforms and innovative solutions for traditional and biometrics enrollment, personalization, issuance, and border control services, SuperCom has helped governments, and national agencies design and issue secured multi-identification, or Multi-ID, documents and robust digital identity solutions to their citizens, visitors, and lands.

The company has focused on expanding its activities in the traditional identification, or ID, and electronic identification, or e-Gov, markets, including the design, development, and marketing of identification technologies and solutions to governments in Europe, Asia, America, and Africa using SuperCom’s e-Government platforms.

Market Opportunity

Data from Berg Insight estimates the market for electronic monitoring solutions will grow from $1.2 billion in 2021 to $2.1 billion in 2026, marking a CAGR of 10.8% for the forecast period.

High recidivism rates, prison overcrowding, and soaring incarceration costs are some factors that are driving the electronic monitoring of offenders’ market growth.

An analysis by ReportLinker forecasts that the global cybersecurity market will grow from an estimated value of $173.5 billion in 2022 to $266.2 billion by 2027, achieving a CAGR of 8.9% for the period.

The increased number of data breaches worldwide, the ability of malicious actors to operate from anywhere in the world, the links between cyberspace and physical systems, and the difficulty of reducing vulnerabilities and consequences in complex cyber networks are some factors driving the cybersecurity market growth.

Management Team

Ordan Trabelsi is President and CEO of SuperCom. He has over 15 years of experience as CEO, growing high-tech companies globally. He also has experience in research and development and product innovation, as well as hands-on experience in cybersecurity, encryption, advanced mathematics, and mobile and internet network technologies. Prior to joining SuperCom, he served as co-founder and CEO of Klikot Inc., a global social networking company. He holds an MBA from Columbia University and a B.Sc. in Computer Engineering from The Technion: Israel Institute of Technology.

Barak Trabelsi is COO of SuperCom. He has expertise in big data, cyber, mobile, and internet network technologies, as well as extensive experience in product development and strategies. Prior to joining SuperCom, he served as Senior Product Manager at Equinox Ltd. Before that, he served for four years as VP of R&D at Sigma Wave, a wireless, security, and internet-focused company. He holds a B.Sc. in Computer Science and Business, as well as an MBA from Tel Aviv University.

Gil Alfi is VP of Sales at Safend Ltd., SuperCom’s cybersecurity subsidiary. He joined SuperCom in 2016 as VP of Business Development for Safend. He has more than 18 years of experience in technology companies. He served as an R&D team technology lead for more than seven years and as Director of Product Management for various telecom and wireless companies for more than 10 years. Prior to joining SuperCom, he served as Regional Sales Director at Safend, managing sales regions in Europe and Africa. He holds a B.Sc. in Computer Science and Mathematics and an M.Sc. in Computer Science from Bar-Ilan University.

SuperCom Ltd. (NASDAQ: SPCB), closed Friday's trading session at $0.1823, up 5.7425%, on 3,821,526 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $7.40/$.

Recent News

FuelPositive Corp. (TSX.V: NHHH) (OTC: NHHHF)

The QualityStocks Daily Newsletter would like to spotlight FuelPositive Corp. (NHHHF).

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a leading green ammonia company, is announcing the completion of on-farm commissioning of its first scalable Green Ammonia production system. The company also shared that it has received numerous visits from interested farmers, stakeholders, and new association members eager to see its system in person at the Hiebert's farm in Sperling. The announcement noted that this interest highlights the potential FuelPositive's technology and business model holds for the agricultural sector, particularly for farmers. "We are excited and prepared to activate ammonia production in our first on-farm system and demonstrate our groundbreaking technology to the world. Currently, we are awaiting the final go-ahead from the province before proceeding. Unfortunately, our team was inaccurately informed of the completion and timeline of two necessary Manitoba certifications. We have addressed this issue. While these approvals are essential to comply with Manitoba's requirements and to complete the final activation of the system, we are confident that we are compliant and that obtaining these certifications is a formality. We will continue to advise on this progress," Ian Clifford, Co-Founder and CEO, said.

To view the full press release, visit https://ibn.fm/Z21Wh

FuelPositive Corp. (TSX.V: NHHH) (OTC: NHHHF) is a growth stage company focused on licensing, partnership and acquisition opportunities building upon various technological achievements. The company is committed to providing commercially viable and sustainable clean energy solutions, including carbon-free ammonia (NH3), for use across a broad spectrum of industries and applications.

FuelPositive is headquartered in Toronto, Canada.

Hydrogen Economy Problems and FuelPositive’s Carbon-Free Technology

The hydrogen economy is currently facing many challenges. Traditional NH3 manufacturing exists on a massive scale, but centralized facilities result in some of the world’s most concentrated CO2 emissions. In total, an estimated 200 million metric tonnes of NH3 are consumed each year, with greater than 80% utilized by the agricultural sector. NH3 is also being positioned as a viable alternative to fossil fuels.

FuelPositive’s flagship carbon-free ammonia technology provides an innovative solution to these environmental concerns. Developed by Dr. Ibrahim Dincer and his team, the company’s platform allows for the in-situ production of NH3 in an entirely sustainable manner, using only water, air and sustainable electricity.

The production of hydrogen is energy intensive, but it is just one variable hindering the growth of the hydrogen economy. Other hurdles include:

  • Storage – The storage of hydrogen by compression or liquification are both cost prohibitive and unsustainable.
  • Distribution – The distribution network for effective hydrogen deployment has yet to be developed, as the extreme high-pressure distribution requirements to transport hydrogen would result in enormous infrastructure costs.
  • End Use – R&D on the transportation-related end use applications for hydrogen is in its infancy, but almost any vehicle on the road today can be easily converted to run on NH3 at a considerably lower cost per mile traveled when compared to traditional fossil fuels.

A key benefit of FuelPositive’s patent-pending, first-of-its-kind carbon-free NH3 technology is its flexibility. The process allows for small, medium or large-scale production of NH3 on location, minimizing or even eliminating the challenges and volatility associated with storage and transportation to end use. As such, with an appropriately sized FuelPositive system and access to renewable energy, the end use applications for the company’s platform are nearly infinite.

Manufacturing Partnership

On May 19, 2021, FuelPositive announced its selection of National Compressed Air Canada Ltd. (“NCA”) to undertake manufacturing of the company’s Phase 2 hydrogen-ammonia synthesizer commercial prototype systems for carbon-free ammonia production.

In a news release detailing the partnership, FuelPositive CEO Ian Clifford noted, “This critical milestone for FuelPositive will confirm the broad application potential for our technology and is the backbone of our Carbon-Free Hydrogen-NH3 offering. Partnering with the knowledgeable and experienced team at NCA on this commercialization project will bring our development-stage program to life.”

Global Ammonia Market Outlook

The global ammonia market was valued at $52.71 billion in 2017 and is forecast to reach $81.42 billion by 2025, growing at a CAGR of 5.59%, according to data from Fior Markets (https://ibn.fm/1OfOB).

The agricultural industry consumes more than 80% of global NH3. Smaller percentages can be attributed to the waste, water treatment, refrigerants, antiseptic, textile, mining and pharmaceutical industries.

One of the most polluting industries on the planet consists of conventional agribusinesses. These polluters are responsible for more greenhouse emissions per year than transportation. This is where FuelPositive’s technology is expected to be extremely beneficial.

Management Team

Ian Clifford is Director, CEO and Founder of FuelPositive Corp. He has over 25 years of experience in the fields of technology and marketing and has successfully led the company to global brand recognition through its unique energy solutions. Since 2006, Mr. Clifford has raised over $50 million in equity financing for FuelPositive. He also co-founded digIT Interactive, a full-service internet marketing company serving Fortune 500 clients, which he sold at the peak of the market in 2000.

Greg Gooch serves as a Director and President of FuelPositive. His multifaceted career in the electronics and finance industries has positioned him as a key advisor and funding partner to start-ups and new technology companies for over 40 years. Mr. Gooch has been involved with FuelPositive since its early days and has remained a significant supporter and consultant to the company over the years. He has a bachelor’s from McGill University and an MBA from the University of Western Ontario.

Dr. Ibrahim Dincer is a scientific advisor to FuelPositive and is recognized as a pioneer and international leader in the area of sustainable energy technologies. Along with his team, Dr. Dincer invented the modular carbon-free ammonia (NH3) production technology that FuelPositive is commercializing. His area of specialty covers various topics including ammonia, hydrogen energy and fuel cells; renewable energy systems; energy storage systems and applications; carbon capturing technologies, and integrated and hybrid energy systems He is currently managing an exemplary team of researchers in this commercialization project.

Marek Warunkiewicz is the company’s Communications & Branding Specialist. He brings more than 40 years of entrepreneurial expertise to the FuelPositive team, having held marketing, branding, advertising, project management and graphic design positions with various companies. Mr. Warunkiewicz has successfully created business-to-business marketing and advertising campaigns for a diverse group of clients ranging from high-tech to agriculture. He co-founded digIT Interactive and ZENN Motor Company alongside Ian Clifford.

Luna Clifford is the Director of Communications for FuelPositive. She has over 10 years of experience as a business owner and advisor, helping build and operate several successful start-up enterprises while managing complex stakeholder relationships. Ms. Clifford excels in strategic planning and team building, and she has completed extensive studies in the fields of communications and health care.

FuelPositive Corp. (NHHHF), closed Friday's trading session at $0.0354, up 5.6716%, on 150,490 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.03/$0.07.

Recent News

Astiva Health

The QualityStocks Daily Newsletter would like to spotlight Astiva Health

new survey has determined that the share of employers who still provide health benefits to retirees has been decreasing over time, reaching 21% as of last year. The survey was carried out by Kaiser Family Foundation (KFF), a leading health policy organization in the United States. The survey's objective was to examine the extent to which states were offering health benefits to eligible retirees under Medicare, via Medicare Advantage arrangements. This analysis was based on KFF's review of employee-retirement-system sites for different states. The survey determined that almost all the states along with the District of Columbia offer health benefits to retirees of Medicare age. The only states that didn't offer retiree health benefits to state retirees aged 65 and above were found to be Nebraska and Idaho. It should be noted that the survey did not center on health benefits for active employees, pre-65 retirees, retirees with separate retirement systems in some states such as teachers or law enforcement, or country- and municipal-granted retiree health benefits. Additionally, the survey didn't include U.S. territories or Puerto Rico. The survey documenting the extent to which states are offering MA plans shows that providers such as Astiva Health and others in various states are making a notable contribution to the delivery of health coverage for different groups of people.

Astiva Health is a dynamic and innovative Medicare Advantage Prescription Drug (MAPD) health plan committed to reshaping the landscape of personalized and comprehensive healthcare. The company offers full medical, drugs, and supplemental benefits for Medicare enrollees, currently serving counties in California, including Orange, San Diego, Los Angeles, Riverside, and San Bernardino. This broad coverage reflects Astiva Health’s dedication to reaching a diverse demographic and addressing the healthcare needs of individuals across Southern California.

Astiva Health primarily serves a heretofore underserved Asian American and Pacific Islander population, which positions it in a critical and expanding market segment and offers substantial growth potential. The company recognizes the diverse needs within its served communities and strives to bridge healthcare gaps through proactive and culturally responsive solutions.

Astiva Health cares about its members and works to establish lifelong relationships with them by providing a tailored approach to healthcare, offering multilingual solutions for customer service, marketing materials and educational resources. Health is an essential key to living a good life, and Astiva Health makes it a priority to help members love the life they live.

The company’s mission is to deliver an unparalleled level of quality care to its members. Astiva Health’s Medicare Advantage plans provide lower costs and additional benefits beyond original Medicare coverage.

Founded in southern California, Astiva Health has strategically positioned itself in a region with a dynamic and diverse population. The organization’s extensive network and culturally responsive approach to healthcare make it well-suited to cater to the needs of the local community, creating a competitive advantage in the market.

The company is based in Orange, California.

Healthcare Model

Astiva Health is not just another health plan. The company considers the uniqueness of its members and, therefore, the means for delivering quality care to each one. To best serve its members, Astiva Health has developed one of the most diverse networks in southern California, offering a selection of medical, drugs, and supplemental benefits including dental, acupuncture, vision and hearing plans tailored to the specialized needs of individual members.

The company’s health plans provide increasing levels of benefits to members in the counties it serves. Astiva Health’s Customer Care Support and representatives are available to assist members with any issues.

The organization’s proactive approach to overcoming language barriers for the Vietnamese communities demonstrates a commitment to inclusivity and enhances accessibility – a key factor for future growth. The successful implementation of strategies for the Vietnamese community sets a precedent for Astiva Health’s ability to adapt and apply similar approaches to serve other ethnic groups in future expansions, broadening the potential impact of its services.

The company provides members access to experienced and dedicated providers and local pharmacies that work together with each member to pave a pathway toward better health. The company’s online directory provides members with a comprehensive list of providers to fit their specialized needs.

Astiva Health collaborates with a variety of partners who offer supplemental benefits to members beyond Medicare. Those benefits include transportation, vision, dental, hearing, fitness, tele-health, acupuncture and chiropractic. Astiva’s forward-thinking strategy not only fulfills a critical societal need but also ensures sustainable growth and transformative impact across diverse communities.

Market Opportunity

Medicare Advantage plans, since their establishment in 2008 as a lower-cost alternative for Medicare enrollees looking to save on monthly premiums, have been one of the fastest growing segments of the health insurance market.

According to a report by healthcare consultant Charts, nearly 31 million beneficiaries are enrolled in a Medicare Advantage plan in 2023, accounting for more than 48% of the total Medicare market. That represents 9.6% enrollment growth over 2022 totals, and the pace of growth is likely to continue, according to the Charts report.
Startup Medicare Advantage plans, a sector that includes Astiva Health, grew even faster for 2023, at a rate of 22% over 2022 totals.

Management Team

Dr. Tri T. Nguyen is co-founder and CEO of Astiva Health. He is a graduate of Stanford Medical School and is a board-certified expert in internal medicine, cardiovascular disease and interventional cardiology. As founder, CEO and owner/operator of Avanta IPA, he is a committed leader in healthcare. His visionary leadership, hands-on experience and deep industry knowledge uniquely position him to guide Astiva to success.

Chi Luong is CFO at Astiva Health. She founded and operates HADD Group LLC, a company managing medical clinic services, including business contracting, finance, staffing and ancillary support for several medical clinics in San Diego. She is responsible for the expansion and daily operation of the business functions of the medical clinics managed by HADD Group, and she has extensive knowledge and experience in healthcare business development.

Viet Tran has over 30 years of experience in engineering research, development and management. He has made numerous contributions to national network security and technology. He led the initial Naval Interoperability Profiles that set a solid foundation for future naval airborne network development. He also led a team of 50 engineers, doctorates and scientists delivering an airborne network system for the Navy’s first carrier-based unmanned aircraft. As Astiva Health’s Chief Operating and Technology Officer, member satisfaction has been his top priority. He is committed to protecting valuable data for Astiva members and providers. He constantly strives for leaner and more effective operations.

Tyler Diep is Vice President, Sales, Marketing and Provider Relations at Astiva Health. His responsibilities include handling special projects for the board of directors, as well as overseeing the sales, marketing and provider relations department. During his tenure, he tripled the membership of Astiva Health. He previously served as councilman and vice mayor of the City of Westminster, California. He immigrated to the U.S. with his parents and graduated from San Diego State with a bachelor’s degree in public administration.

Recent News

chart

Annovis Bio Inc. (NYSE: ANVS)

The QualityStocks Daily Newsletter would like to spotlight Annovis Bio Inc. (NYSE: ANVS).

The study shows buntanetap is effective in enhancing both motor and cognitive functions, as well as non-motor activities in Parkinson's Disease patients

Following the announcement of these positive results, the company's stock price surged by 76%

The data revealed that while 12% of Parkinson's Disease patients showed cognitive decline, buntanetap not only halted this decline but also led to improvements

Annovis held a webcast to go over the results in more depth, which is available for replay on the company's website

Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer's Disease and Parkinson's Disease, has released new data from its Phase III study of buntanetap for early Parkinson's Disease. The study shows buntanetap is effective in enhancing both motor and cognitive functions, as well as non-motor activities in Parkinson's Disease patients (https://ibn.fm/5ZqlC).

Annovis Bio Inc. (NYSE: ANVS) is a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s Disease (AD) and Parkinson’s Disease (PD). Annovis Bio stands out by developing a drug that targets multiple neurotoxic proteins simultaneously, aiming to restore axonal and synaptic activity. This innovative approach aims to treat memory loss and dementia associated with AD and body and brain dysfunction associated with PD, making Annovis a unique player in the neurodegeneration space.

Lead Drug Candidate: Buntanetap

Buntanetap (formerly Posiphen) targets neurodegeneration by inhibiting the formation of multiple neurotoxic proteins, including amyloid beta, tau, alpha-synuclein, and TDP43. This multifaceted inhibition improves synaptic transmission and axonal transport, reduces neuroinflammation, and protects nerve cells from dying. Unlike monoclonal antibody therapies, Buntanetap is an orally available small molecule capable of inhibiting multiple neurotoxic proteins at once, positioning it as a comprehensive solution for neurodegenerative diseases.

In a recent Phase II/III Alzheimer’s study, Buntanetap demonstrated statistically significant efficacy. Patients with early AD showed a significantly higher rate of improvement in ADAS-Cog 11 scores across all treatment doses compared to placebo, with a -3.3 point improvement compared to -0.3 for placebo (p < 0.01). Plasma Tau protein levels also reduced, consistent with previous Phase II biomarker data, further validating Buntanetap’s mechanism of action.

Similarly, in the Phase III study of Buntanetap in patients with early Parkinson’s disease, significant advancements were observed. Topline data results are anticipated in June 2024. Preliminary findings indicate promising results in improving cognitive and motor function, underscoring Buntanetap’s potential as a transformative therapy for Parkinson’s disease.

Market Opportunity

The aging population presents a significant market opportunity, with nearly 7 million Americans currently suffering from Alzheimer’s Disease (AD), a figure projected to rise to almost 13 million by 2050 (Alzheimer’s Association) (Republican Policy Committee). Additionally, approximately 1.2 million people in the U.S. have Parkinson’s Disease (SingleCare).

The economic burden of Alzheimer’s is immense, with care costs expected to reach $360 billion in 2024 and escalate to nearly $1 trillion annually by 2050. The need for effective, comprehensive treatments like Buntanetap is more critical than ever.

Company Highlights

  • Innovative Therapeutic Approach: Annovis Bio uniquely targets multiple neurotoxic proteins, aiming to restore nerve cell health and improve cognitive and motor function in AD and PD patients.
  • Robust Clinical Data: Phase II/III studies show significant improvements in cognitive function and biomarker levels in early AD patients.
  • Groundbreaking Clinical Insights: Preliminary results from Phase II studies indicate significant improvements in motor functions and speed in patients with Parkinson’s Disease (PD).
  • Upcoming Phase III Trials: Plans are underway for an 18-month Phase III trial focusing on biomarker-positive early AD patients, designed to further validate Buntanetap’s disease-modifying potential.
  • Capital Efficiency: Annovis Bio is capital-efficient, with zero debt and multiple global patents extending into the 2040s.

Management Team

Maria L. Maccecchini, Ph.D., Founder, President, CEO, and Executive Board Member, founded Annovis Bio in May 2008 with the mission to develop better therapeutics for Alzheimer’s, Parkinson’s, and other neurodegenerative diseases. She has previously been a partner and director at two angel groups, Robin Hood Ventures and MidAtlantic Angel Group, and founded Symphony Pharmaceuticals/Annovis, which was sold to Transgenomic in 2001. Her extensive experience includes roles such as General Manager at Bachem Bioscience and Head of Molecular Biology at Mallinckrodt. Dr. Maccecchini holds a Ph.D. in biochemistry from the Biocenter of Basel, with postdoctoral work at Caltech and the Roche Institute of Immunology.

Cheng Fang, Ph.D., Senior VP of Research and Development, is an accomplished neuroscientist with two decades of experience in neurodegenerative diseases. She has a successful track record of scientific publications and contributions, coupled with extensive pre-clinical and clinical development experience. Dr. Fang has been instrumental in advancing the understanding of neurodegenerative disease mechanisms and developing therapeutic strategies.

Michael Christie, Ph.D., VP of Process Chemistry, has over 40 years of experience in the pharmaceutical industry, focusing on process chemistry R&D, pilot plant production, and GMP operations. He has held senior management positions at companies such as SmithKline, Rhodia, Teva, and Cephalon, and founded a contract process R&D service company, which was later acquired by ChiRex. Dr. Christie is co-author or co-inventor on several publications and patents. He earned his BS in chemistry from the University of Michigan and his doctorate from MIT.

Melissa Gaines, Senior VP of Clinical Operations, is an accomplished clinical research professional with over 20 years of experience across academia, contract research organizations, and pharmaceutical companies. She has proven abilities in monitoring and managing Phase I to IV clinical trials, specializing in CNS disorders and extending to a broad range of therapeutic indications. Her CNS experience spans from small Phase I and II studies to large global Phase III trials in Alzheimer’s disease, Parkinson’s disease, sleep disorders, and various psychiatric diseases in both adult and pediatric populations. In her current role, she oversees and supports all clinical project activities, driving operational success and ensuring high-quality clinical outcomes.

Learn more about the Annovis Bio team on LinkedIn.

Annovis Bio Inc. (NYSE: ANVS), closed Friday's trading session at $11.33, off by 0.5267779%, on 444,256 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $4.53/$22.49.

Recent News

First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF)

The QualityStocks Daily Newsletter would like to spotlight First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) .

Despite its reliance on coal-fired energy to power its massive manufacturing sector, China has made such significant strides in green-energy production that the fossil fuel's contribution to China's energy mix has fallen even lower. Renewable energy production in the country surpassed its electricity demand growth in May as coal's share in China's energy mix dropped to a record 53%, while renewables produced a historic 44% of the country's electricity in March. Analysis by Asia Society Policy Institute fellow Lauri Myllyvirta also found that greenhouse-gas emissions in China may have peaked last year. Myllyvirta also serves as a lead analyst at the Center for Research on Energy and Clean Air (CREA). His recently published analysis noted that solar-power generation expanded by 78% or 41 TWh and represented more than 50% of the renewable energy produced in May. Hydropower also bounced back from the 2022–2023 droughts and increased by 39% or 34TWh. Myllyvirta's analysis indicates that the trends behind the fall in cement and fossil-fuel emissions in March 2024 could endure for the time being. If the deployment of wind and solar capacity continues at current rates, 2023 could be the peak year for China's emissions as renewables steadily replace fossil fuels in energy generation. As many more companies such as First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) continue to avail the metals needed to power the green-energy transition around the world, more countries could see their use of fossil fuels decrease as renewables take over.

First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) is committed to exploring for and providing essential and critical metals, including tellurium, gold, silver, copper and tungsten, for North American markets. This objective is anchored by the company’s Deer Horn tellurium-gold-silver-copper project in British Columbia, Canada, and further enhanced by its property option on the Klondike tellurium-gold prospect located in Colorado, USA.

First Tellurium’s unique business model is to generate revenue and value through mineral discovery, project development, project generation and cooperative access to untapped mineral regions in indigenous territory with sustainable exploration potential.

The company is headquartered in Vancouver, British Columbia.

Tellurium and the Green Energy Revolution

Tellurium has a key role to play in the ongoing green energy revolution. It is widely used in the manufacturing of photovoltaic cells for solar panels.

Despite this utility, ongoing trade tensions between China and the U.S. create implications for both tellurium and the production of cadmium-tellurium solar cells. Earlier this year, China announced plans to restrict exports of critical metals gallium and germanium, both essential for the production of semiconductors. For reference, China produces around 80% of the world’s gallium and approximately 60% of the world’s germanium.

China’s recent trade restrictions amplify the fragility of the North American tellurium supply, as the Asian nation currently produces about 60% of the world’s tellurium. This sustained supply vulnerability is why First Solar, the United States’ largest solar panel producer, set up a worldwide search for tellurium deposits in the mid-2000s.

“In North America alone, our understanding is that First Solar looked at over a hundred tellurium properties,” First Tellurium CEO Tyrone Docherty stated in a news release. “Their number one property by far, which they acquired, was the Colorado Klondike which we now control.”

The U.S. is now looking to secure safe, domestic sources of tellurium and many other critical metals to pre-empt potential shortages. The Biden administration has instituted a stream of policies, particularly the U.S. Inflation Reduction Act, to source solar components from North America and other “friendly” jurisdictions.

As the only junior mining company in the world focused on tellurium exploration, First Tellurium is ahead of the curve in capitalizing on these initiatives to establish strategic, domestic supplies of key resources for solar panel manufacturers.

First Tellurium’s ESG Initiatives

Through its exploration and partnerships with Fenix Advanced Materials, Cheona Metals and IRMA, First Tellurium strives to generate a measurable, beneficial social or environmental impact alongside a financial return. The company conducts a diversified search for metals, working in alliance with indigenous peoples, NGOs, governments and leading metals buyers. First Tellurium believes this is the future of mineral exploration — generating revenue by exploring responsibly and leveraging diverse partnerships.

First Tellurium proudly adheres to, and supports, the principles and rights set out in the United Nations Declaration on the Rights of Indigenous Peoples and, in particular, the fundamental proposition of free, prior and informed consent.

 

Projects

Deer Horn Tellurium-Gold-Silver-Copper Project

Deer Horn is located on 51.33 square kilometers (km) in west-central British Columbia, 36 km south of the prolific Huckleberry copper-molybdenum mine and 135 km southwest of the community of Burns Lake. It is one of few significant tellurium discoveries outside Asia and includes a 2.4 km-long vein system of high-grade gold, silver and tellurium, as well as broader zones of bulk-tonnage gold, silver and tellurium mineralization. The company completed a positive Preliminary Economic Estimate and has begun permitting for a 10,000-tonne bulk sample program to advance the project toward mine feasibility. It is North America’s only silver-gold-tellurium property with an NI 43-101 compliant tellurium resource, and it hosts a number of other mineralized targets and zone containing critical metals such as copper, tungsten and zinc.

First Tellurium owns 50% of the property, with an option to acquire up to a 75% interest. The company has engaged Dias Geophysical of Saskatoon, Saskatchewan, to conduct induced polarization (IP) geophysics on the Deer Horn Project in summer 2023. The program is designed to help develop drill targets for a subsequent drilling program.

Klondike Gold-Tellurium Project

The Klondike property is located in Saguache County, Colorado, southwest of Buena Vista in the state’s historical mining district. The company reports it has engaged Burgex Mining Consultants of Sandy, Utah, to stake additional claims around the Klondike property. The claims have been filed with the Bureau of Land Management.

Klondike demonstrates exceptional tellurium grades. Tellurium, used in high-efficiency cadmium telluride (Cd-Te) solar panels, next-generation lithium-ion batteries and thermoelectric devices to change heat into energy, is an essential element for the world’s transition to green energy.

The Klondike property was a top tellurium prospect owned previously by First Solar Inc., one of the world’s largest solar panel producers. First Solar terminated its worldwide raw materials exploration program in 2012 and sold the property to Colorado Klondike LLC, which optioned the project to First Tellurium. Colorado Klondike, led by First Solar’s former Exploration Manager in North America, is managing the upcoming exploration program.

The Colorado Geological Survey (CGS), in partnership with the Colorado School of Mines, reported on First Solar’s exploration at Klondike in 2015, noting: “Surface sampling by First Solar, Inc. in 2006 found very high tellurium grades of up to 3.3% (33,000 ppm), along with locally high gold grades. Tellurium grades at Klondike were the highest encountered in the company’s nationwide exploration program.”

Market Outlook

First Tellurium in spring 2023 referenced recent forecasts by the International Energy Agency (IEA) pointing to rapid growth in solar photovoltaic (solar PV) deployment worldwide. According to the agency, solar PV installations will generate more power by 2027 than any other energy source, including coal, natural gas and hydro. To meet this demand, consumption of both silver and tellurium, key components of solar panels, is expected to surge in coming years.

Chen Lin, founder of Lin Asset Management, has written in his investment newsletter for clients that solar PV is now the largest industrial usage of silver. He said that in 2022 solar PV production used about 12% of total silver demand, or about 120 million ounces of silver. Lin expects this number to rise dramatically in the coming years, and that is likely to lead to silver supply deficits for decades to come.

Lin points out that solar power is now the cheapest source of energy in many parts of the world and that all forecasts point to dramatic expansion of solar PV in the coming two decades. Conservative estimates forecast 300 gigawatts of solar PV production by 2027, up from the current level of about 200 gigawatts.

Management Team

Tyrone Docherty is President, Director and CEO of First Tellurium Corp. He previously served as President and CEO of Quinto Mining Inc., taking over when it had a market cap of $4 million. With limited resources in a difficult market environment, he raised more than $30 million and advanced Quinto’s Quebec iron ore property to a viable project. Quinto later sold for $175 million, with Quinto management taking shares of the purchaser, Consolidated Thompson Iron Mines, amounting to approximately 20-21% of that company. Consolidated Thompson Iron Mines sold two years later for $4.9 billion, giving the former Quinto team an enterprise value of approximately $1 billion. From 2012 to 2018, Mr. Docherty was Director and Chairman of Mason Graphite Inc. He has worked in the financial and minerals markets for more than 30 years.

Tony Fogarassy, M.Sc. LL.M., is Chairman of First Tellurium Corp. He is a lawyer and a geologist. His extensive legal and technical expertise includes minerals, oil and gas, coal and renewable energy projects and environmental and aboriginal/indigenous law in North America, Africa and Asia. He graduated as gold medalist in geological sciences from the University of British Columbia and in law from the London School of Economics.

First Tellurium Corp. (OTCQB: FSTTF), closed Friday's trading session at $0.092, off by 3.1579%, on 28,000 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.047785/$0.1075.

Recent News

Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF)

The QualityStocks Daily Newsletter would like to spotlight Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF).

The use of artificial intelligence around the globe is increasing as days go by, as is energy consumption by the technology. Senior research analyst at the Allen Institute for AI, Jesse Dodge, has been conducting research on how AI consumes energy. Thus far, researchers have determined that artificial intelligence uses a lot more power to generate its answers as compared to traditional internet. One report by Goldman Sachs determined that an inquiry made on ChatGPT required almost 10 times as much electricity as a question posed on Google. It is expected that as artificial intelligence advances, the need for energy shall continue to increase. Currently, the growing data center industry is focused on northern Virginia. Forecasts expect that this region will need energy that could power six million households by 2030 to meet the energy demand from data centers. Entities that are focused on implementing ESG principles, such as Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF), may need to think through their energy use as this metric alone could hold the potential to delay the attainment of emissions reduction in the way that Microsoft and Google provide examples.

Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) is a strategic minerals company focused on locating and developing economic properties in the strategic metals and advanced materials space. The company aims to improve domestic specialty mineral infrastructure efficiencies to meet surging national demand from North American manufacturers, effectively positioning itself as one of the only North American suppliers of high purity natural graphite for hi-tech applications.

Reflex Advanced Materials is based in Vancouver, British Columbia. Its project portfolio includes the Ruby Graphite Deposit in Montana and the ZigZag Lithium Property in Ontario.

Projects

Ruby Graphite Project

Located in a mining-friendly jurisdiction in southwest Montana, the Ruby Graphite Deposit is a low cost, rapid re-entry opportunity that produced roughly 2,400 tons of graphite from 1902 to 1948. Reflex Advanced Materials holds mining rights for 755 hectares at the Ruby Graphite Project, with 96 federal lode mining claims. Recent samples assay at 95.8% to 98.4% total carbon.

The site is notable as the only combined U.S. graphite flake and vein graphite source. Vein graphite is ideal for energy storage applications, because it requires fewer steps to achieve purity than synthetic alternatives and is therefore far less environmentally damaging. This is expected to play a key role in the project’s development as demand for electric vehicles continues to surge.

In March 2023, the company announced its submittal of permit applications to the Bureau of Land Management in respect of its exploration of the Ruby Graphite Project. Its initial drill program, expected to take place in the summer of 2023, includes plans for 3,500 total meters of drilling, cored to an average depth of 130 meters. The targets for this drill program have been identified using historical data from original mine operations and data gathered for the initial 43-101 technical report on the project, dated January 31, 2023.

ZigZag Lithium Property

Located in the Thunder Bay Mining Division of Ontario, the ZigZag Lithium Property consists of eight mining claims spanning roughly 2,710 hectares. Mineralization at the property, most notably lithium, is based in pegmatite dikes and concentrated in spodumene crystals, which are consistent throughout the entire unit.

Spodumene is readily observable in outcrops and in drill cores, with crystal sizes ranging from 3-15cm, on average.

Reflex Advanced Materials and American Energy Technologies Company Metallurgical Partnership

Reflex Advanced Materials has entered into a material processing agreement with American Energy Technologies Co., which is based in Arlington Heights, Illinois, to conduct metallurgical testwork with the goal of creating a technical support data package for Reflex’s target customer base, U.S. Federal agencies and qualification programs with hi-tech customers in the battery and battery storage business.

The resulting coated, spherionized, purified graphite (CSPG) material that is expected to be created from the aforementioned tests will be used to provide potential customers of CSPG with samples so that they can begin the material qualification process.

Market Opportunity

Graphite is an ideal battery anode and has dominated the market since the proliferation of lithium-ion batteries. Despite this demand, there is currently no significant production of lithium-ion battery anode material in North America.

Instead, most graphite sold in North America today is sourced from Chinese producers. U.S. President Joe Biden highlighted this sourcing disparity in a 2022 address:

“The United Stated depends on unreliable foreign sources for many of the strategic and critical materials necessary for the clean energy transition – such as lithium, nickel, cobalt, graphite and manganese for large-capacity batteries,” he said. “Demand for such materials is projected to increase exponentially as the world transitions to a clean energy economy.”

The U.S. Department of Energy is in the process of awarding $2.8 billion to expand domestic manufacturing of batteries for electric vehicles and combat this foreign dependency. Reflex Advanced Materials has identified its Ruby Graphite Project as a prime candidate for U.S.-sponsored initiatives due to the rarity and scarcity of natural graphite deposits in the country.

Processing graphite domestically in the U.S. is expected to provide Reflex Advanced Materials a competitive advantage as manufacturers begin to seek out American supply in the face of increased diplomatic tension. This is critical, as a rise in anode demand is expected to fuel a shortage of 8 million tonnes of graphite by 2040. World Bank Group projects 494% growth in total graphite demand by 2050.

Leadership Team

Paul Gorman is the CEO and a Director of Reflex Advanced Materials. He brings to the company over 25 years of experience in junior mining finance, public listings, viability assessment and operational rationalization. For 18 years, Mr. Gorman served as president and managing partner of Riverbank Capital, where he played an instrumental role in raising more than $85 million for small-cap companies. In 2008, he funded Industrial Minerals Inc. (later Northern Graphite) and served in an advisory role for four other graphite companies, contributing significantly to the revitalization of the junior graphite space in North America. Mr. Gorman founded Mega Graphite Inc. in 2009 and has served as chief executive for three other companies.

Tasheel Jeerh, CPA, is the company’s CFO. He is a finance and accounting professional with over a decade of experience spanning both public and private sectors. Prior to joining Reflex Advanced Materials, Mr. Jeerh played a pivotal role in the growth of a private upstream oil and gas firm, dealing with over $2 billion in M&A activity and $1 billion in financing activities. He gained his designation at PricewaterhouseCoopers, where he worked as a manager in the assurance practice.

Greg Bell is Project Manager for Reflex Advanced Materials. He is a multi-disciplined engineering management professional with more than 40 years of experience in the natural resources sector. Mr. Bell has successfully built and managed several start-up operations in various capacities. He has been active in graphite and lithium exploration for the past seven years.

Christopher W. Hill leads the company’s Corporate Development initiatives. He is an investor and entrepreneur with over a decade of experience in the capital markets. Mr. Hill began his career as an investment advisor and then began to consult and advise private companies on their paths to becoming publicly traded. He specializes in corporate development and strategic financing utilizing his large network in the capital markets.

Reflex Advanced Materials Corp. (RFLXF), closed Friday's trading session at $0.0315, off by 40.566%, on 100 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0306/$0.35.

Recent News

Correlate Energy Corp. (OTCQB: CIPI)

The QualityStocks Daily Newsletter would like to spotlight Correlate Energy Corp. (OTCQB: CIPI).

Correlate Energy Corp. (OTCQB: CIPI) is a publicly-traded company strategically positioned to capitalize on America’s unstoppable trend toward decentralized energy generation.

The energy grid in the U.S. is insufficient for the booming clean energy trend, and current infrastructure is limiting green energy distribution. Constructing the needed infrastructure to address this demand imbalance will cost billions and be far too slow, positioning decentralized systems, like those on offer from Correlate, in a key position for heightened demand.

Correlate has identified several key economic drivers powering the decentralized energy trend, including:

  1. Real Cost Savings – Customer pays zero money down and gets an instant electrical price discount to current rates.
  2. Massive Project Investment Funding – The International Energy Agency estimates that over one billion dollars per day will be invested in solar energy in 2023.
  3. Consistent Long-Term Incentives – The Inflation Reduction Act is a game-changer, supercharging renewables with $1.2 trillion in tax credits for 10 years of market support.
  4. Robust Customer Demand – Wood Mackenzie expects the U.S. solar industry to nearly triple in size over the next five years.

Correlate’s team of multi-decade experts who have worked with renowned global brands are positioning the company to make the most of this opportunity while consolidating a fragmented industry. Collectively, the team has developed, financed and deployed over $2 billion in clean energy projects to date.

Three-Pronged Strategy

Correlate is leveraging a three-pronged strategy aimed at driving shareholder value:

  1. Sell – Correlate seeks to finance, develop and profitably sell localized clean energy solutions and microgrids to industrial, commercial and residential customers.
  2. Retain – Correlate plans to retain ownership of some of these energy systems and thereby realize ongoing, reliable cash flow.
  3. Acquire – Correlate seeks to acquire proven renewable energy companies in order to exponentially grow earnings per share for investors.

This strategy is enhanced by current investment trends. Clean energy earnings are being sought after by investors. In Q4 2022, the median EBITDA multiple for green energy companies was 12.3x, according to Finerva.

Market Outlook

Over the next decade and beyond, renewable energy growth is expected to come primarily via decentralized systems like those offered by Correlate.
The Inflation Reduction Act enacted in late August 2022 is likewise expected to drive growth for the company by providing new tax incentives that reduce costs for clients and/or elevate returns to investors.

Commercial buildings consume more than 35% of the generated electricity in the U.S. and are underperforming in energy efficiency at every level. These buildings waste energy, emit too much carbon and are too costly for owners and occupants, but retrofits are not happening at the rate or scale needed.

In today’s real estate market, portfolio property owners own most commercial buildings, yet most building efficiency work is focused on single buildings, thereby missing the distinct needs of this owner class which are very different from traditional owner-occupiers. The diverse nature of commercial buildings, combined with technology and performance uncertainty, make simple energy optimization initiatives – which could greatly reduce energy use and improve building value – financially unattractive, resulting in slow adoption rates. CIPI’s financial instruments and software breakdown this issue, known as the ‘split incentive’, unlocking the majority of the addressable market.

A key portion of Correlate’s strategy relates to consolidation of what has been a fragmented industry. By uncovering opportunities to improve efficiencies through strategic M&A activities, the company intends to enhance profitability throughout its operations.

Management Team

Todd Michaels is President and CEO of CIPI and founder of Correlate. He formerly served as Vice President for Innovation at SunEdison and Senior Director Distributed Solar at NRG Energy. He founded Correlate in 2015 and has 16 years of experience in the energy industry. He graduated from Indiana University with a B.S. in Computer Information Systems.

Channing Chen is CFO at CIPI and Correlate Inc. and brings over 16 years of experience in the solar industry as a developer, financier, and business unit leader. He has held executive management roles at Solar Power Partners (acquired by NRG Energy), where he was a founding employee, SunEdison, and NRG Energy (NYSE: NRG). Most recently, Mr. Chen was founder and Managing Partner at Breakaway Energy Partners LLC – a distributed energy financing and market-making platform. To date, Mr. Chen and his teams have raised over $1.5 billion in financing across residential, commercial, and utility scale solar and energy storage projects representing over 400 MWs. He holds a B.A. in Environmental Chemistry from the University of California at San Diego and an MBA from the University of Southern California. He is also an advisor and early-stage investor to several startup companies in the renewable energy space.

Dave Bailey is Chief Revenue Officer of Correlate Inc. With over 15 years of executive sales, supply chain management, and energy efficiency experience, he is responsible for ensuring the success of the National Commercial Sales Unit across multiple regional project teams. Mr. Bailey created and launched the Transformation Services team while at Wesco for its multibillion-dollar Distributed Energy Resource division, formerly Westinghouse. His focus was on IoT-enabled efficiency and plant floor automation-based services. Before that, he spent several years in Global Account Sales Management, with GE Supply as a Program Manager, and is a Commercial Leadership Program graduate. Mr. Bailey received his B.S. in Mechanical Engineering from the University of Kentucky.

Jed Freedlander is the company’s Chief Development Officer. He has a background in infrastructure development and investment and a strong legal, commercial and finance acumen. Mr. Freedlander has a proven track record in leading complex public-private partnership (P3) and energy transactions and is instrumental in driving Correlate’s strategic development initiatives.

Roger Baum is Executive VP Operations at Correlate. With over 20 years of experience at Core Construction, he brings to the company a wealth of knowledge and a strong track record in delivering successful commercial construction projects.

Jason Loyet is Director of Solar Energy for Correlate Inc. He is a cleantech executive with over 20 years of experience leading high growth solar energy and software start-ups. Mr. Loyet is a U.S. Department of Energy SunShot Catalyst award winner for his work building the Solar Site Design technology platform. Before joining the solar energy industry in 2005, he founded and sold two software companies in the streaming media (GlobalStreams) and newspaper publishing (MyCapture) industries. Mr. Loyet currently serves as a Member of the Board of Directors for the Tennessee Solar Energy Industry Association (TenneSEIA).

Correlate Energy Corp. (OTCQB: CIPI), closed Friday's trading session at $0.41, up 54.717%, on 2,300 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.05/$2.35.

Recent News

Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF)

The QualityStocks Daily Newsletter would like to spotlightFathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF).

Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) is a Canadian natural resource development and exploration company that targets high-grade nickel sulfide discoveries for use in the rapidly growing global electric vehicle (EV) market. The company has a portfolio of two high-quality exploration projects located in the prolific Trans Hudson Corridor in Saskatchewan.

Led by a management team with more than 100 years of combined mining and exploration experience, Fathom believes in a continuing bright outlook for nickel and its increasing use in the manufacturing of batteries needed for energy storage in the high-growth renewable energy and EV industries. The company’s modern approach to exploration has yielded significant new nickel discoveries.

Fathom is headquartered in Calgary, Alberta.

Projects

The Albert Lake Project

The Albert Lake Project comprises 90,460 hectares of lands located in north-central Saskatchewan, with over 80,000 hectares currently unexplored. The project is host to the historic Rottenstone Mine, a high-grade, open pit nickel sulfide past producer that was active from 1965 to 1969 and yielded ~26,000 tonnes of 3.3% Ni, 1.8% Cu, and >9 g/t Pd-Pt+Au.

The geological setting of the Albert Lake Project is within the Trans Hudson Orogeny (Corridor), which is host to numerous world-class nickel mining camps including the Thompson Nickel Belt (currently operating with more than 5 billion pounds of nickel produced since 1959), Lynn Lake (past producer) and Raglan Nickel Belt (currently operating with more than 39,000 tons of nickel produced in 2020).

The project is fully permitted. Exploration plans for 2024 include drilling a high-priority target located approximately 2km south of the historic Rottenstone Mine along with drilling other high-priority targets. Additional soil geochemistry, surface geophysical programs and geological mapping and prospecting will be performed during the summer field season.

The Gochager Lake Project

The Gochager Lake Project in northern Saskatchewan, also in the prolific Trans Hudson Corridor, was recently expanded through the addition of the contiguous Watt’s Lake property and direct staking, bringing its total land area to 22,620 hectares.

The Gochager Lake property is host to a historic resource defined by drilling in 1966-1967 consisting of 4.2 M tons grading 0.29% Ni and 0.08% Cu. Recent drilling by Fathom has defined multiple very robust off-hole borehole electromagnetic (BHEM) responses in eight of nine holes drilled in 2023 and three historic drill holes probed. There is very strong evidence of multiple, high-grade nickel-copper-cobalt steeply oriented chutes within the historic Gochager Lake Deposit.

Prior to Fathom exploration in 2023 and since 1970, exploration at the property has been limited to small drill programs in 1989-1990 and 2018. Exploration plans for 2024 include expanded surface geophysical programs, drilling and continued BHEM surveys to expand tons and increase the grade of the historic Gochager Lake deposit. Summer exploration will consist of soil geochemistry, mapping, prospecting and additional surface geophysical programs focused on identifying other Gochager-like deposits within the current land package.

Market Opportunity

Nickel plays a crucial role in clean energy technologies, and that is expected to cause demand to well outstrip supply for the foreseeable future.

With an annual market value of around $35 billion, nickel demand is projected to rise due to its intensive use in lithium-ion batteries used to power EVs. However, new discoveries of nickel sulfide deposits (currently the most reliable source for battery-grade class 1 nickel) have been rare, which could constrain class 1 nickel supply in the coming years.

According to Deloitte’s global EV forecast, total EV sales will grow from 2.5 million in 2020 to 11.2 million in 2025, reaching 31.1 million by 2030 and representing approximately 32% of the total market share for new car sales. Over the next 10 years, the EV market is projected to see a CAGR of 29%, with increased demand for nickel expected to be comparable.

Management Team

Fathom Nickel has assembled a best-in-class leadership team consisting of highly qualified industry professionals with deep knowledge and understanding of the mineral exploration industry and capital markets.

Ian Fraser, P.Geo., is CEO, VP Exploration and Co-Founder of Fathom Nickel. He has more than 35 years of experience in mineral exploration, as well as managing and implementing exploration projects in Canada and internationally. His experience includes resource interpretation and development of the Casa Berardi Gold Mine and Komis Gold Mine, as well as the Cisneros Gold Mine in Colombia.

Doug Porter, CPA, CA, CBV, is President, CFO and Director of Fathom Nickel. He is a senior financial and accounting executive with specific emphasis in resource company management. His career includes positions with Elan Coal Ltd., Altitude Resources Ltd. and StimWrx Oilfield Services Ltd.

Fathom Nickel Inc. (OTCQB: FNICF), closed Friday's trading session at $0.0441, up 19.1892%, on 40,419 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0222/$0.2588.

Recent News

Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF)

The QualityStocks Daily Newsletter would like to spotlightFathom Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF).

Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) is a publicly traded Canadian minerals exploration company focused on exploring high-grade copper and gold deposits in North America. The company owns the Storm Copper Project and the Seal Zinc Deposit in Nunavut, Canada, and is currently exploring the Buckingham Gold Vein and critical metals prospects in central Virginia. Aston Bay is also in the advanced stages of negotiation on other properties with high-grade critical minerals potential in these areas.

The company believes in responsible exploration and carries out its work programs to the highest standards of social responsibility, environmental stewardship and health and safety. Aston Bay cares about leaving a net positive impact on the communities in which it works and engages with local representatives, Indigenous groups and government agencies to build respectful relationships through dialogue and collaborative processes. Depending on the stage of exploration, these efforts may include employment, contracting, training, community benefits and other agreements.

Aston Bay conducts exploration through safe, socially and environmentally responsible and sustainable work practices. The company embeds core values of health and safety throughout its operations by adhering to strict health and safety standards and practices that meet and/or exceed industry standards and government codes and regulations.

The company is headquartered in Toronto.

Projects

Storm Copper

The high-grade Storm Copper Deposit is located 112 kilometers south of the community of Resolute Bay, Nunavut, on western Somerset Island, just south of the past-producing Polaris Pb-Zn Mine. The property comprises 173 contiguous mining claims, including the Storm Copper and Seal Zinc projects, covering an area of approximately 541,795 acres.

The property has good access to established shipping lanes, and the landscape provides favorable conditions for development of roads and a protected deep-water port. Exploration is supported through excellent infrastructure in the nearby hamlet of Resolute Bay.

Aston Bay is partnered with American West Metals (ASX: AW1) at Storm. American West is responsible for all exploration expenditures, having aggressively advanced the project toward production and earned an 80% interest. This affords excellent optionality to the company’s shareholders, as Aston Bay is free carried with no required expenditures until the completion of a bankable feasibility study.

American West recently completed an Australian JORC-compliant Maiden Resource Estimate for Storm; the North American 43-101 compliant resource estimate is expected in Q1 2024. American West is cashed up and plans a multimillion-dollar resource expansion and new discovery drilling program for the summer of 2024.

The Buckingham County Gold Project

The gold-bearing system at the Buckingham County Gold Project in Virginia lies within a belt hosting past producing mines, current gold mines and advanced gold explorations, stretching through Georgia, the Carolinas, Virginia, Nova Scotia and Newfoundland.

Buckingham hosts a “Kirkland Lake-style” high grade gold vein returning values consistently over one ounce gold per ton and is underexplored both at depth and along almost one mile of strike length. These types of veins have excellent ESG qualities, as they are typically mined using a small footprint underground method, with gold extracted using simple and environmentally friendly gravity methods.

Market Opportunity

The World Gold Council, the industry association for the world’s gold producers, estimated in 2023 the physical financial gold market, which is made up of bars, coins, gold ETFs and central bank reserves, is worth nearly $5 trillion. The council reports that gold mine production adds approximately 3,500 tons of the precious metal to the world’s supply annually, equivalent to about 2% growth.

This historical scarcity and relatively slow production of new supply, as compared to other commodities, is a primary reason gold has retained its value for millennia, according to the council.

A report from Acumen Research and Consulting, a global provider of market intelligence and consulting services, valued the global copper market at $304.1 billion in 2022 and forecast that it will reach a market size of $496.8 billion by 2032, growing at a CAGR of 5.1% over the forecast period.

The report identifies a growing demand for copper in the electronics industry, as well as an expanding copper supply due to increasing production from existing mines and the rising number of mine development projects in developing nations, as driving factors in the rising value of the copper market.

Management Team

Thomas Ullrich is CEO and Director of Aston Bay. He has over 30 years of experience in mineral exploration and geoscience. Before joining Aston Bay, he was Chief Geologist North America for Antofagasta Minerals plc, investigating copper potential through extensive property evaluations and management of drill programs in the United States, Mexico and Canada. Prior to that, he was Senior Geologist for Almaden Minerals.

Sofia Harquail handles Investor Relations and Corporate Development at Aston Bay. She has over 15 years of experience in the private and public sectors of the mining industry. Before joining Aston Bay, she worked as a consultant for the Prospectors and Developers Association of Canada and for exempt market dealer Red Cloud Financial Services Inc. Ms. Harquail holds an M.A. from the University of Uppsala in Sweden and received her CPIR designation from the CIRI/Ivey Investor Relations Program. She also sits on the board of the Young Mining Professionals Toronto and is CSC Certified.

Aston Bay has a talented Board of Directors bringing broad experience from across the industry, encompassing resource expansion, mine development, mergers and acquisitions, and mining finance.

Ms. Jessie Liu-Ernsting has over 15 years of experience in the mining industry, spanning capital projects engineering, debt capital markets, private equity and corporate strategy at several firms, including Hudbay Minerals and Resource Capital Funds. She is currently VP Investor Relations and Communications at G Mining Ventures Corp.

Mr. Jeffrey R. Wilson has over 25 years’ experience in the mining industry, having served as a director, officer and advisor of multiple public and private companies in the mineral exploration and mining investment industries. Mr. Wilson is currently President & CEO of Precipitate Gold Corp.

Mr. Gary O’Connor has over 40 years of diverse experience as a mineral exploration and development professional in the management of successful resource projects as well as the evaluation, technical due diligence, and supervision of large mineral exploration and development projects through-out the world. While with Freeport, Mr. O’Connor worked on the due diligence and discovery of a major gold fraud on the Busang gold “deposit” in Kalimantan by Bre-X.

Mr. Mark J. Pryor is a geologist with a 40-year track record of successfully advancing multiple precious metal, copper, coal, REE and Li projects from discovery through to exploitation. He is currently Executive Vice President of the Exploration Division at The Electrum Group.

Aston Bay Holdings Ltd. (OTCQB: ATBHF), closed Friday's trading session at $0.0852, up 7.6437%, on 2,000 volume. The average volume for the last 3 months is 49,196 and the stock's 52-week low/high is $0.0268/$0.2474.

Recent News

SenesTech Inc. (NASDAQ: SNES)

The QualityStocks Daily Newsletter would like to spotlight SenesTech Inc. (NASDAQ: SNES).

SenesTech Inc. (NASDAQ: SNES) is the rodent fertility control expert and the inventor of the only EPA-registered contraceptive for male and female rats. The company’s technology provides an innovative and humane method for managing rat populations.

SenesTech is focused on developing effective solutions that are grounded in science and proven through research, all while providing value to people, communities and the environment. The company’s passion is to create a healthier world by better controlling rat pest populations. This aim is critical, as, if left unchecked, a breeding pair of rats and their descendants can produce up to 15,000 pups after just one year.

The company strives for clean cities, efficient businesses and happy households – with a product that was scientifically designed to be effective without killing rats. SenesTech is committed to the sustainable, humane treatment of animals, improving the quality of all human life and enhancing environmental stewardship through the global application of its effective solution in fertility control technology.

SenesTech is headquartered in Phoenix, Arizona.

ContraPest®

SenesTech’s first product, ContraPest®, applies revolutionary technology to a global challenge that has persisted since the Middle Ages – the proliferation of rats in urban and agricultural settings. ContraPest® targets the reproductive capabilities of Norway and roof rats. As a highly palatable liquid, the formulation promotes sustained consumption, helping to reduce fertility in both male and female rats, bringing populations down and keeping them down.

The company’s flagship offering can be used as part of integrated pest management (IPM) programs – fitting seamlessly into all IPM programs – to help reduce reproduction and magnify the success of these protocols, or as a standalone solution for customers who want to reduce or eliminate the use of lethal rodent control methods.

In multiple, independent field deployments, ContraPest was shown to reduce rat activity over 90% when added to an existing IPM program.

ContraPest® is registered federally as a General Use Product.

Delivery Systems and New Products

In July 2023, SenesTech began to distribute a new delivery system for ContraPest®, the Isolate Bait System™. This new delivery system brings to market a simple design that enables more efficient deployment, incorporates an enhanced formulation of ContraPest® that is expected to provide improved performance of the fertility control bait in the field and is paired with a new bait station that is more space-efficient and economical.

The other delivery systems available for ContraPest include the Ultimate Bait System™, a tank and tray in a larger format for use with more severe infestations, and the Elevate Bait System™, a unique delivery system that targets above ground infestations, as with roof rats.

SenesTech, as of August 2023, is also in the final stages of releasing a soft bait formulation, which provides the unique attributes of proven fertility control in an industry-familiar format demanded by big box retailers, key e-commerce channels and leading industry pest management professionals.

Market Opportunity

According to SenesTech’s figures, rats cause over $27 billion in damage to public and private infrastructure annually in the United States. Rats also destroy 20% of the global stored food supply every year by consuming or contaminating it.

Rats are known to spread at least 35 diseases, globally posing a dangerous risk to public health and safety. Not only does this age-old problem persist despite extensive campaigns to eradicate it, but multiple sources have reported that post-COVID rat populations have boomed.

Poison-based control methods sicken rats, and they typically die slowly. An animal that eats a poisoned rat may also sicken or die. The global rodenticide market is projected to be worth $1.7 billion by 2026.

In one case study, results reported by the customer showed a $5,000 investment in ContraPest® saved more than $500,000 annually in reduced labor, loss and damage.

Management Team

Joel Fruendt is SenesTech’s President and CEO. He has 15 years of executive leadership in the vector and pest control industries as Vice President and General Manager of Clarke Environmental Inc., a leading vector and pest control products and services company. He has extensive expertise in the development and manufacturing of EPA-registered chemical control products, and the commercialization and sale of those products. He received the ‘Smart Leaders’ award from Smart Business Magazine and holds a bachelor’s degree in business from Illinois Wesleyan University.

Tom Chesterman is CFO at SenesTech. He has over 20 years of experience as the CFO of public companies in the life science, tech and telecommunications industries. Most recently, he was the Vice President and Treasurer of GCI, a telecommunications company. Previous to that, he was the CFO of life science companies Bio-Rad Laboratories, Aradigm and Bionovo. He has a bachelor’s degree from Harvard University and an MBA from the University of California at Davis.

Dan Palasky is Chief Technical Officer at SenesTech. Previously he held the title of Vice President of Research & Development at PLZ Corp., a manufacturer of chemical consumer products, serving as the technical expert for its entire product portfolio. He started his career with Camie-Campbell, Inc., as a chemist in the R&D department. Mr. Palasky received his bachelor’s degree in chemical engineering from the Missouri University of Science & Technology and his MBA in Project Management from Aspen University.

SenesTech Inc. (NASDAQ: SNES), closed Friday's trading session at $0.54, up 1.8868%, on 13,165 volume. The average volume for the last 3 months is 94,428 and the stock's 52-week low/high is $0.491/$11.76.

Recent News

HeartBeam Inc. (NASDAQ: BEAT)

The QualityStocks Daily Newsletter would like to spotlight HeartBeam Inc. (NASDAQ: BEAT) .

HeartBeam Inc. (NASDAQ: BEAT) is a cardiac technology company that has developed the first and only 3D-vector 12-lead electrocardiogram (ECG) platform for heart attack detection anytime, anywhere. The company’s proprietary ECG telehealth technology aims to redefine the way high risk cardiovascular patients are diagnosed in ambulatory and acute care settings. HeartBeam’s initial focus is on providing diagnostic data to help physicians with care management of patients with cardiovascular disease.

In August 2022, HeartBeam announced that it submitted its HeartBeam AIMI™ software for approval from the U.S. Food and Drug Administration (FDA). HeartBeam AIMI is a platform technology to improve the speed and accuracy of heart attack detection in acute care settings. The company expects FDA approval by the end of 2022, and a full commercial roll-out of HeartBeam AIMI is targeted for Q1 2023.

HeartBeam sees submission of its first product based on its platform technology as an important milestone toward commercialization, which underscores the company’s continued progress toward making the HeartBeam AIMI platform widely available to help emergency department physicians quickly and accurately identify a heart attack.

While the FDA conducts its regulatory review, HeartBeam will focus on executing key components of its commercialization plan and subscription revenue model. It will also continue to engage in discussions with strategic institutions, including academic centers, regional healthcare systems and regional community hospital systems that can utilize HeartBeam products.

The company is based in Santa Clara, California.

Products

HeartBeam’s development portfolio includes two products:

  • HeartBeam AIMI is software that provides a 3D comparison of baseline and symptomatic 12-lead ECG to more accurately identify a heart attack in acute care settings and, as noted above, has been submitted for FDA approval; and
  • HeartBeam AIMIGo™, the first and only credit card-sized 12-lead output ECG device coupled with a smartphone app and cloud-based diagnostic software system for remote heart attack detection.

HeartBeam is developing AIMIGo, a medical-grade detection and monitoring technology for use in remote heart attack detection, thereby allowing physicians to diagnose a patient’s heart attack as it occurs, even if the patient is not at a medical facility. The company’s system, once approved by the FDA, can be used by patients at home or almost anywhere and anytime to help their physicians assess whether chest pain is the result of a heart attack or another cause. While approximately 82% of chest pain ED visits are unnecessary, patients delay approximately 3 to 4 hours after symptoms begin, increasing mortality rates by 40%. The company’s goal is to shorten the time to treatment outside of the medical facility to improve patients’ well-being.

HeartBeam’s AIMIGo is a powerful, portable and easy-to-use prescription-based product. It comprises a smartphone app, a credit card-sized ECG device placed on a patient’s chest, the HeartBeam cloud platform, and a digital portal for the physician to view ECG results and direct patient action. For the first time outside of a medical setting, HeartBeam AIMIGo enables patients and their clinicians to determine if symptoms are due to a heart attack, quickly and easily, so care can be expedited, if needed.

Pending FDA clearance, AIMIGo is initially intended to be available by prescription, and is reimbursable under existing remote patient monitoring codes (RPM codes). This provides a new revenue stream to physicians who before did not have a way to monitor these high-risk patients. The RPM codes provide a monthly reoccurring revenue stream to the company, as well. On average, at current reimbursement rates, the practice will receive $1,300+ per year per patient they monitor, and the company will receive $600 per year per patient from this RPM reimbursement.

Market Overview

Adoption rates of telehealth services increased dramatically in recent years, with the COVID-19 pandemic serving as a major driver of growth. Among the areas seeing the greatest expansion are cardiology, radiology, behavioral health and online consultation.

Encouraging this growth, governments are actively developing new policies and reimbursement guidelines to promote the use of digital health platforms. The U.S. Centers for Medicare & Medicaid Services (CMS), for example, has recently expanded reimbursement for telehealth services. U.S. market growth is also being driven by the rising prevalence of chronic conditions and the growing geriatric population.

Remote heart attack detection is a previously unsolved problem with a massive and underserved market that is several times larger than the $2 billion total addressable market (TAM) in the U.S. for ECG cardiac arrhythmia monitoring.

Approximately 8 million Americans have suffered at least one heart attack, and a total of 18 million have been diagnosed with coronary artery disease (CAD). Based on these figures, HeartBeam projects a total addressable U.S. market TAM valued at $10 billion annually for its AIMIGo solution for remote heart attack monitoring of CAD.

Management Team

Branislav Vajdic, Ph.D., Chief Executive Officer and Founder of HeartBeam, Inc, combines over 30 years of experience in technology development and senior management positions. Dr. Vajdic has been deeply involved with the development of HeartBeam’s technology to fit his vision for the company. Prior to HeartBeam, from 2007 to 2010, Dr. Vajdic was CEO and Founder of NewCardio, a publicly traded company in the cardiovascular devices space. From 1984 to 2007, Dr. Vajdic was at Intel, where he held various senior management position. At Intel, Dr. Vajdic was the designer of first Flash memory and two key inventions that enabled Flash as a product and led engineering groups responsible for Pentium 1 through Pentium 4 designs. Dr. Vajdic was awarded two Intel Achievement Awards, the highest level of award for outstanding contributions to Intel. Dr. Vajdic is author of numerous patents and publications in the fields of cardiovascular devices, as well as chip design. Dr. Vajdic holds a Ph.D. in Electrical Engineering from the University of Minnesota.

Jon Hunt, Ph.D., has over 35 years’ experience in the medical/medical device industry with extensive domestic and international experience in general management, clinical/regulatory, sales and marketing. He also has diverse experience in Fortune 500 companies, as well as start-up environments. Dr. Hunt was the Vice President of Clinical Science and Technology, Medical Device Innovation Consortium, from July 2019 to July 2021, and Vice President of Clinical and Regulatory Affairs, Cryterion Medical from January 2018 to June 2019 (acquired by Boston Scientific Corporation in July 2018 for $202M). Dr. Hunt was the Founding President and CEO of Bardy Diagnostics, Inc. from October 2013 to November 2017 (acquired by Hill-Rom Holdings, Inc.). Prior to joining Bardy Diagnostics, Dr. Hunt spent the previous 11 years as the Vice President of Clinical & Regulatory Affairs with Cameron Health, Inc. (acquired by Boston Scientific Corporation). Dr. Hunt spent the previous 10 years with Cardiac Pacemakers, Inc., St. Jude Medical and Cardiac Pathways Corporation. Dr. Hunt began his career with Cardiac Pacemakers, Inc. (now Boston Scientific Corporation) as the Director of Clinical Programs. He subsequently held positions at St. Jude Medical in Clinical Affairs and as the Business Unit Director for the Cardiac Rhythm Management division for Europe, the Middle East and Africa. At Cardiac Pathways Corporation, Dr. Hunt held various executive positions as Vice President of International Sales and Marketing and Vice President of Worldwide Sales and Marketing (acquired by Boston Scientific Corporation). Dr. Hunt received his Ph.D. in Motor Control from The Pennsylvania State University, his Master’s from California State University, Long Beach and his undergraduate degree from Keele University in the United Kingdom.

Rick Brounstein, HeartBeam’s Chief Financial Officer, combines over 30 years of experience in health technology senior management. Since 2017, Mr. Brounstein has been and is currently a partner of Hardesty, LLC, a financial services firm, and Mr. Brounstein is currently a managing director of CTRLCFO, LLC, a firm Mr. Brounstein founded in 2016 to support funded start-ups in life science and technology. From 2008 to 2011, Mr. Brounstein was Chief Financial Officer of NewCardio, Inc., a microcap public company in the cardiology space, and, over his career, he has been with nine other companies in life science or technology, holding positions including Chief Financial Officer, Chief Operating Officer, Treasurer and Accounting Manager. From June 2001 through November 2007, Mr. Brounstein held several positions at Calypte Biomedical Corporation, a publicly traded medical device company, including Chief Financial Officer and Executive Vice President. In January 2007, Mr. Brounstein was appointed as the National Member Representative for the 2007 COSO Monitoring Project, which published new guidelines for monitoring internal financial controls in February 2009; Mr. Brounstein subsequently was a member of the FEI task force that issued the updated COSO Internal Control Framework in 2013. In March 2005, Mr. Brounstein was appointed to the SEC Advisory Committee on Smaller Public Companies. Mr. Brounstein earned his Certified Public Accountant (CPA) certification while working at Arthur Andersen LLP, formerly a public accounting firm. Mr. Brounstein holds a B.A. in accounting and an M.B.A. in finance, both from Michigan State University.

Ken Persen, HeartBeam’s Chief Technology Officer, combines over 28 years of experience in the medical device and digital health industries in engineering and senior management positions. Mr. Persen has been involved in several companies in Cardiac Rhythm Management, holding positions including Chief Executive Officer, Chief Technology Officer, Executive Vice President and Director of Engineering. Since 2016 and prior to joining HeartBeam, Mr. Persen was the Chief Technology Officer at LIVMOR, Inc., a digital health company. In addition, from 2016 through November 2021, he was also Chief Executive Officer of LIVMOR. Prior roles included Director of Engineering at Cameron Health (acquired by Boston Scientific), a late-stage medical device start up, and engineering and management positions at Guidant Corp. (acquired by Boston Scientific), a large medical device manufacturer. He has an undergraduate degree from University of Minnesota, Duluth, with a BA in Computer Science.

HeartBeam Inc. (NASDAQ: BEAT), closed Friday's trading session at $2.78, up 1.4599%, on 22,858 volume. The average volume for the last 3 months is 116,068 and the stock's 52-week low/high is $1.06/$3.3893.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.